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ABSTRACT
Schneider, Maryia M. Current trends in marijuana methods of ingestion and associated
problems among young adult marijuana users. Doctor of Philosophy Dissertation,
University of Northern Colorado, 2020.
The legal status of marijuana in the United States has been ever changing in the
last few years, with many states legalizing marijuana for medicinal as well as recreational
use—leading to increasing numbers of retail outlets. This rise in retail outlets has led to
diversified methods of marijuana ingestion. The current study sought to understand the
effect of methods of ingestion on frequency of use, problematic use, marijuana use
motives, mental health, and marijuana use trajectories measured over five years.
Additionally, the current study sought to understand the effect of contextual factors on
method of ingestion and source of marijuana as well as transitions in methods over five
years. Finally, this study strived to understand differences in endorsed reasons for
choosing certain methods of ingestion. MANCOVA, Chi-square, Fisher’s Exact, and
Ordinal logistical regression analyses were conducted on a sample of 257 participants.
The current study found that method of ingestion was not significantly related to
frequency of use, problematic use, use motives, mental health, nor use trajectories. This
study did find significant relationships regarding certain contextual factors as well as
endorsed reasons for choosing certain methods of ingestion. These results serve as a
foundation in understanding the relationship between methods of ingestion and associated
problems, to help support prevention and intervention strategies and mitigate negative
results of marijuana use.
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CHAPTER I
INTRODUCTION
Attitudes towards marijuana in the United States have been changing over the last
few years (Gallup, 2017). This has given rise to multiple states legalizing marijuana use
for adult medicinal and recreational use. It is still very unclear what effect this
legalization will have on state economics, legal systems, and public health. Rates of
marijuana use among Americans is high, with 38.7% of young adults ages 18-25
reporting marijuana use in the past year and 22.1% reporting use in the past month
(Substance Abuse and Mental Health Services Administration, 2019). Rates of marijuana
use among school-aged youth are increasing, with 16.7% of youth ages 12-17 reporting
use in the past year, and 6.6% reporting use in the past month (Substance Abuse and
Mental Health Services Administration, 2019). These numbers may be even higher, as
several states have legalized marijuana for medicinal and/or recreational purposes
following this annual publication. A body of evidence specific to recreational marijuana
use is urgently needed to guide, prioritize, and evaluate public health and policy efforts
(Allen et al., 2017).
When considering marijuana use, it is important to discuss changes in methods of
ingestion over recent years, as more methods have become accessible to users with the
changing legalization climate. The following introduction outlines a study that examines
current trends and associated problems related to marijuana use ingestion among young
adult marijuana users.
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Significance of the Problem
Marijuana is the most commonly used, federally illicit drug in the United States.
Attitudes towards marijuana have become increasingly more accepting, with 64% of
adults in favor of recreational use (Gallup, 2017). These increasingly accepting attitudes
have given rise to legalization of marijuana for both medical and recreational use. As of
May 2020, marijuana is legal for adult recreational use in 11 states and the District of
Columbia, and medicinally legal in 46 states with considerable state-to-state variation in
the regulations and laws in each state (National Conference of State Legislatures, 2020).
The changing legal status of marijuana in the United States has led to increasing diversity
and availability of methods of ingestion, as well as increased potency in the marijuana.
Currently, minimal research exists on the effects that methods of marijuana
ingestion may have on different outcomes. Looking into effects of method of ingestion
becomes increasingly important as marijuana becomes legal for adult recreational use in
more states. Method of marijuana ingestion has the potential to influence one’s use (e.g.
ability to vape or use edibles in public, leading to increased frequency), and research is
needed to understand these possible influences and guide prevention and intervention
strategies as well as public policy.
Marijuana is defined as a “Schedule 1” substance by the Federal Drug
Enforcement Agency. A “Schedule 1” substance is defined as a substance with no
accepted medical use and a substantial risk of addiction (Comprehensive Drug Abuse
Prevention and Control Act, 1970; Federal Controlled Substance Act, 1970). Ninety-two
million (28.6%) Americans ages 12-25 reported marijuana use in the past month.
Approximately 1.6 million (6.5%) adolescents reported marijuana use in the past month
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in 2017, similar to the percentages in 2015 and 2016. In contrast, 7.6 million (22.1%)
young adults ages 18-25 were current users of marijuana in 2017, which is higher than
the percentages between 2002 and 2016 (Substance Abuse and Mental Health Services
Administration, 2018). These numbers are alarming, especially given that the legal age of
consumption for marijuana in states with recreational use is age 21. In addition to high
prevalence rates for adolescents, research has shown there is a high level of similarity in
the median age of initiation for marijuana, with a median age of onset across multiple
countries between 18 to 19 years of age (Degenhardt et al., 2008). These numbers are
concerning for school psychologists, as many adolescents will begin using marijuana
during high school. School psychologists are in prime positions to aid in prevention and
intervention efforts across multiple settings for those who are starting use before high
school graduation.
Marijuana refers to the dried leaves, flowers, stems, and seeds harvested from the
Cannabis sativa or Cannabis indica plant. Delta-9-tetrahydrocannabinol (THC) is the
primary proactive ingredient in marijuana (National Institute on Drug Abuse, 2018),
giving marijuana its mind-altering effects. Marijuana is comprised of many cannabinoids
unique to the plant. There are several subclasses of cannabinoids that are most commonly
studied including THC and Cannabidiol (CBD). CBD does not produce mind-altering
effects. Researchers, including the National Institute of Health (NIH) are exploring the
possible uses of CBD for medical treatment (National Institute on Drug Abuse, 2018b).
While related to THC, CBD is not the focus on the current study. Marijuana can be
consumed in many ways, including: smoking (inhaling via small pipes/joints/blunts/water
pipes), vaping (inhaling a smokeless vapor associated with marijuana), dabbing
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(ingesting a more concentrated form of marijuana), oral (edible), and
sublingually/topically (applying tinctures/creams to the skin). Methods of ingestion have
been changing rapidly in the new legalization climate. In addition, many forms of
marijuana are being used, including marijuana (flower), dabs (highly concentrated
forms), edibles, and topical formulations. Marijuana dispensaries or retail stores are
motivated to increase sales through increasing the variety of products available to
consumers (Borodovsky, Crosier, Lee, Sargent, & Budney, 2016; Pacula, Kilmer,
Wagenaar, Chaloupka, & Caulkins, 2014; Pacula, Powell, Heaton, & Sevigny, 2015).
Many adverse short- and long-term consequences of marijuana use have been
identified through research. Marijuana has been associated with cognitive (e.g., Solowij
et al., 2002; Tapert, Schweinsburg, & Brown, 2008), psychological (e.g., Hall & Pacula,
2003; Kalant, 2004), and injury-related factors (e.g., Hall & Pacula, 2003). Long-term,
chronic marijuana use is associated with marijuana dependence, as well as tolerance and
withdrawal symptoms (Budney & Hughes, 2006; Budney, Moore, Vandrey, & Hughes,
2003; Chen, Storr, & Anthony, 2009; Copersino et al., 2006; Davis, Smith, Morphew,
Lei, & Zhang, 2016; Hasin et al., 2015; Hasin et al., 2017; Karila et al., 2014; Katz,
Lobel, Tetelbaum, & Raskin, 2014; Kouri & Pope, 2000; Volkow, Baler, Compton, &
Weiss, 2014; Wen, Hockenberry, & Cummings, 2015). Regular marijuana smokers report
pulmonary concerns (e.g., Owen, Sutter, & Albertson, 2014; Tashkin, Baldwin, Sarafian,
Dubinett, & Roth, 2002;). Research has consistently found long-term marijuana use to be
associated with cognitive deficits across multiple areas (see Crane, Schuster, Fusar-Poli,
& Gonzalez, 2013 and Solowij & Battisti, 2008 for reviews), neurological changes (see
Broyd, van Hell, Beale, Yücel, & Solowij, 2016 for a review), and numerous
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psychosocial factors (e.g., education, psychological; Agrawal, Neale, Prescott, &
Kendler, 2004; Fergusson & Boden, 2008; Hall, 2009; Hall & Degenhardt, 2007;
Heitzeg, Cope, Martz, Hardee, & Zucker, 2015; Lynskey & Hall, 2000; Patton et al.,
2002; Volkow et al., 2014). These studies have failed to assess the role method of
ingestion could have on frequency, problematic use, motives for use, and general mental
health outcomes.
In the last decade, research on the developmental trajectories of marijuana use has
been increasing. This research uses group-based developmental trajectory methods to
understand longitudinal patterns of substance use and identify subgroups of users (Kosty,
Seeley, Farmer, Stevens, & Lewinsohn, 2016; Scholes-Balog, Hemphill, Evans-Whipp,
Toumbourou, & Patton, 2016). This research is important as it can identify subgroups of
youth who will escalate to regular and heavy use, and risk factors associated with these
chronic patterns. Studies have found between three and seven developmental trajectory
patterns of marijuana use from adolescence to adulthood, with large samples delineating
more developmental trajectories (e.g. Homel, Thompson, & Leadbeater, 2014;
Schulenberg et al., 2005; Terry-McElrath et al., 2017; Windle & Wiesner, 2004). Across
these developmental trajectory studies, it was found that between 8.3-28% of those who
initiate marijuana use escalate to monthly or more frequent use (Brook, Zhang,
Leukefeld, & Brook, 2016; Ellickson, Martino, & Collins, 2004; Flory, Lynam, Milich,
Leukefeld, & Clayton, 2004; Homel et al., 2014; Scalco & Colder, 2017; Scholes-Balog
et al., 2016; Terry-McElrath et al., 2017). Many of these studies found that early, high
level marijuana users had less favorable outcomes compared to other, lower use
trajectory groups (e.g. Ellickson, Martino et al., 2004; Homel et al., 2014). Many risk
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factors have been associated with chronic heavy or increasing developmental trajectories
including: emotional dysregulation (Brook et al., 2016); aggressive and antisocial
behavior (Passarotti, Crane, Hedeker, & Mermelstein, 2015); conduct problems
(Ellickson, Martino et al., 2004; Flory et al., 2004; Hix-Small, Duncan, Duncan, & Okut,
2004; Scalco & Colder, 2017; Windle & Wiesner, 2004); psychiatric disorders (Flory et
al., 2004; Windle & Wiesner, 2004); temperament (Scalco & Colder, 2017); novelty
seeking (Brook et al., 2016; Ellickson, Martino et al., 2004; Flory et al., 2004; Hix-Small
et al., 2004; Passarotti et al., 2015), to name a few. None of these studies have sought to
understand the role method of ingestion may have on subgroup membership.
Studies have shown contextual factors (e.g., availability, price) of a substance
have many influences on individual use as well as the population as a whole. Research
has found substantial decreases in the price of marijuana since its legalization (Caulkins,
Kilmer, MacCoun, Pacula, & Reuter, 2011; Hall & Lynskey, 2016). Across states where
marijuana is legal, there is considerable variation in their laws regarding the number of
dispensaries. Studies have found higher dispensary density to be related to higher
likelihood of using a variety of methods of ingestion (e.g. Borodovsky et al., 2016, 2017;
Daniulaityte et al., 2015). The allowance of home cultivation also varies by state, but
research has found home cultivation to be associated with higher likelihood and younger
age of onset of marijuana edible use among youth ages 14 to 18 (Borodovsky et al.,
2017). Methods of marijuana ingestion available in a location can depend on its legal
status, and research is needed to identify emerging trends to inform timely prevention and
policy measures, as well as minimize potential dangers of certain methods (Daniulaityte
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et al., 2015; Gourdet, Giombi, Kosa, Wiley, & Cates, 2017; Schauer, King, Bunnell,
Promoff, & McAfee, 2016).
As increasing methods of marijuana ingestion become available, researchers have
explored reasons for selecting certain methods of ingestion. These studies have found that
marijuana users endorsed unique reasons for preferring a method of ingestion that vary
by the specific methods studied (e.g. safer to use, stronger intoxication effect, is easily
accessible, less side effects; Giombi, Kosa, Rains, & Cates, 2018; Lee, Crosier,
Borodovsky, Sargent, & Budney, 2016; Loflin & Earleywine, 2014). Further research is
necessary in this area to understand if these endorsed reasons for preferring a method of
ingestion vary across all methods of marijuana ingestion, as well as if they vary across
other variables including gender, age, and legal status of marijuana.
Purpose Statement
Building off of two social-cognitive/contextual developmental models proposed
by Mayes and Suchman (2006; presented in chapter two), this descriptive, cross-sectional
study sought to understand how young adult marijuana users have transitioned from one
method of marijuana ingestion to another method, how contextual factors might play into
their choice of method, and how reasons for using particular methods differ. In addition,
this study examined how these factors may be associated with marijuana use and
associated psychological problems. Primary methods of marijuana ingestion were as
follows: joints, blunts (cigar sized joints), hand pipe, bong (water pipe), hookah,
vaporizer (e.g. volcano, vape pen), dab rigs, edibles, and other. Primary types of
marijuana ingested included: marijuana (flower), concentrates/dabs, edibles, and other.
Demographics were important to this study in order to help identify characteristics and
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factors contributing to significant differences across outcomes, transitions, patterns, and
reasons for using certain methods. The specific research questions and hypotheses
addressed by this study are:
Q1

Are certain methods of marijuana ingestion related to higher frequency of
use and problematic use?

H1

Methods of ingestion with immediate effects (i.e. smoking, vaping,
dabbing) and potential higher potency (i.e. vaping, dabbing, oral) lead to
increased frequency of use and problematic use.

Q2

Are certain methods of ingestion related to specific motives for use?

H2

Motives for marijuana use vary by primary method of ingestion, and
methods with immediate effects and higher potency are related to coping
motives for use.

Q3

Are certain methods of ingestion associated with negative mental health
outcomes?

H3

Methods of ingestion with immediate effects (i.e. smoking, vaping,
dabbing) and potential higher potency (i.e. vaping, dabbing, oral) lead to
worse general mental health outcomes (e.g. anxiety and depression).

Q4

Are certain methods of ingestion related to historical and current patterns
of use in terms of frequency and transitions in methods from age of onset
to current use?

H4

Chronic and escalating marijuana use patterns are related to methods of
ingestion with immediate effects and potential higher potency.
Additionally, users with multiple transitions between methods of ingestion
are related to chronic and escalation marijuana use patterns.

Q5

Are primary methods of ingestion influenced by contextual factors (e.g.,
availability or awareness of methods)?

H5

Primary method of ingestion is influenced by availability (e.g. legal
status).

Q6

Are endorsed reasons (e.g. safety, type of high, price) for using certain
methods different across methods of marijuana ingestion?

H6

Marijuana users endorse distinct reasons (e.g. safety, type of high, price)
for utilizing certain methods of ingestion.
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Delimitations
This research study has several delimitations. The participants for this study were
self-selected among people recruited through a web forum, which can increase the
potential for non-generalizable results. Since the survey was anonymous and no IP
addresses were collected, it was not possible to identify repeat respondents, if any.
Compensation was not provided for completing the survey, aside from participants
recruited through MTurk who received a small monetary incentive. Limited or no
compensation is a method known to discourage deception and repeat responses (Bowen,
Daniel, Williams, & Baird, 2008). Compensation was provided to participants recruited
through MTurk as it is required as a part of using their platform. Furthermore, the data for
this study were self-reported; however, there is substantial support for the reliability and
validity of self-reported data on substance use behaviors (Adair, Craddock, Miller, &
Turner, 1995), and data obtained via web-based self-administration (Miller et al., 2002).
Another delimitation of this study is the cross-sectional nature of the data. Longitudinal
studies are required to understand causal relationships between methods of marijuana
ingestion and associated problems.
Summary
With increasing numbers of states legalizing marijuana for medical as well as
recreational use, a thorough understanding of methods of ingestion is necessary as
methods of ingestion are becoming increasingly diversified and accessible. The current
study is increasingly important, as marijuana is legalized in more states across the United
States, to help further the research based on marijuana as well as any potential negative
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outcomes that could arise from its legalization. This research can be used to inform
prevention and intervention programs for youth as well as young adults.
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CHAPTER II
REVIEW OF THE LITERATURE
Prevalence and Legal Status
In the United States, marijuana is the most commonly used, federally illicit drug.
As of 2018, 43.5 million Americans ages 12 or older were currently users of marijuana,
an increase of nearly 20 million since 2017 (Substance Abuse and Mental Health
Services Administration, 2018; Substance Abuse and Mental Health Services
Administration, 2019). Attitudes towards marijuana use have been changing over the last
few years, with increasing numbers of individuals in favor of legalization of marijuana
for recreational use (Gallup, 2017). This has given rise to multiple states legalizing
marijuana use for adult medicinal and recreational use. It is still unclear how legalization
will affect legal systems, state economies, social service systems, and public health.
Historical Background
Prior to 1970, marijuana was legal in the United States, and was dispensed
through physicians and pharmacists for various medical purposes. In 1937, the Federal
Marijuana Tax Act was passed. This act did not prohibit the distribution of marijuana. If
one obtained a federal stamp and paid an annual tax or license fee, they were able to
distribute medicinal marijuana. However, there was no application process and the
stamps were unavailable. This effectively outlawed the growth and distribution of
marijuana in the United States (Carliner, Brown, Sarvet, & Hasin, 2017; McKenna, 2014;
Pacula, Chriqui, Reichmann, & Terry-McElrath, 2002). In 1970, the Federal Drug
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Enforcement Agency defined marijuana as a “Schedule 1” substance, with the 1970
Comprehensive Drug Abuse Prevention and Control Act, more commonly known as the
Federal Controlled Substances Act of 1970. This act placed all controlled substances into
five categories, or schedules related to their potential for abuse as well as recognized
medical usefulness. A “Schedule 1” substance is defined as a substance with no accepted
medical use and a high risk of addiction (Comprehensive Drug Abuse Prevention and
Control Act, 1970; Federal Controlled Substance Act, 1970). This act made the use of
marijuana illegal in the United States and implied that there was no currently accepted
medical use for marijuana.
Current Legal Status
Currently as of May 2020, marijuana is legal for adult recreational use in 11 states
and the District of Columbia, and medicinally legal in 46 states with considerable stateto-state variation in the specific provisions of the laws (National Conference of State
Legislatures, 2020). A list of the states and their approved laws related to marijuana can
be found in Table 1. Marijuana is still classified as a “Schedule 1” substance and
considered federally illegal, however, on January 4th, 2018 Attorney General Jefferson B.
Sessions issued a memorandum regarding marijuana enforcement, rescinding previous
nationwide guidance specific to marijuana enforcement, the Cole memorandum. Sessions
stated that enforcement of applicable marijuana laws, regulations, and appropriations will
be determined by prosecutorial discretion (Sessions, 2018).
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Table 1
Individual states approved marijuana laws as of May 2020
State
Medical
Limited Access Medical
Marijuana Law (Low THC/High CBD)
AL
X
AK
X
AZ
X
AR
X
CA
X
CO
X
CT
X
DE
X
DC
X
FL
X*
GA
X
HI
X
ID
IL
X
IN
X
IA
X
KS
KY
X
LA
X**
ME
X
MD
X
MA
X
MI
X
MN
X
MS
X
MO
X*
X
MT
X
NE
NV
X
NH
X
NJ
X
NM
X
NY
X
NC
X
ND
X
OH
X*
OK
X**
OR
X
PA
X
RI
X

Recreational
Marijuana Law
X

X
X

X

X

X
X
X

X

X
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Table 1, continued
State

Medical
Marijuana Law

Limited Access Medical
(Low THC/High CBD)
X

SC
SD
TN
X
TX
X
UT
X*
X
VT
X
VA
X
WA
X
WV
X
WI
X
WY
X
Note. * details pending; ** law not yet in effect

Recreational
Marijuana Law

X
X

As marijuana use has become legal in many states, attitudes towards marijuana
have become increasingly more accepting. The percentage of U.S. adults in favor of legal
recreational use has been steadily increasing with a majority of Americans in favor of
legalization since 2013, and currently resides at 64% in favor of recreational use. This is
a drastic change from the 12% of Americans in favor of legalization in 1969 (Gallup,
2017). This increasingly favorable view of marijuana is also reflected on surveys
completed by adolescents in the U.S. In the Monitoring the Future (MTF) study,
adolescents who perceived moderate or great risk in occasional marijuana use decreased
between 1991 and 2015, from 84.0% to 53.8% (Keyes, et al., 2016). Similar trends were
observed in the National Survey on Drug Use and Health (NSDUH), with almost half of
12th graders reporting no or slight perceived harm in using marijuana once or twice a
week—an increase of almost 25% from 2006 (Azofeifa et al., 2016; Pacek, Mauro, &
Martins, 2015; Sarvet et al., 2017). Although perceived risk in marijuana use is
decreasing among those ages 12-17, rates of marijuana use in this group have not
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increased. However, there has been an increase in use for those ages 18 and older
(Azofeifa et al., 2016).
Prevalence
Approximately 2 million (7.9%) adolescents ages 12-17 in the U.S. report using
illicit drugs in the last month in 2017, while 8.3 million (24.2%) young adults ages 18-24
reported illicit drug use. As stated previously, the most commonly used illicit drug among
these age groups is marijuana, with 9.2 million (28.6%) Americans ages 12-25 reporting
marijuana use in the past month. Approximately 1.6 million (6.5%) adolescents reported
marijuana use in the past month in 2017; this number is similar to the percentages in 2015
and 2016. However, 7.6 million (22.1%) young adults ages 18-25 were current users of
marijuana in 2017; this number has increased and was higher than the percentages
between 2002 and 2016 (Substance Abuse and Mental Health Services Administration,
2018). In comparison, 2.5 million (9.9%) adolescents ages 12-17 drank alcohol in the last
month, with estimates of current alcohol use among adolescents decreasing over the last
15 years. For young adults, 19.3 million (56.3%) reported alcohol use in the last month,
which has been relatively stable over the last 15 years (Substance Abuse and Mental
Health Services Administration, 2018). Past month marijuana use among adolescents
appears relatively stable, while alcohol use has been decreasing. For young adults, past
month alcohol use has been relatively stable, however past month marijuana use has been
increasing. These trends are concerning given that marijuana is still illegal for
recreational use in many states across the United States, and similar to alcohol, the legal
age of consumption for marijuana in places where it is legal is 21.
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Little research has been completed with states that have passed recreational
marijuana laws, and the research that does exist shows mixed results regarding increases
in adolescent marijuana use after passing of medical and/or recreational marijuana laws.
Carliner and colleagues (2017) reported that studies looking into the relationship between
changes in adolescent marijuana use and passing of medical marijuana laws (MMLs)
found there was no effect of MMLs on prevalence of adolescent use. However, another
study found perceived harmfulness among eighth and 10th graders in Washington
decreased 14.2% and 16.1% respectively, while marijuana use increased 2.0% and 4.1%
post legalization, while in Colorado no differences in perceived harmfulness or pastmonth use were found (Cerdá et al., 2017). Colorado has developed a committee to
monitor concerns related to marijuana. In their most recent summary, marijuana use was
found to have been stable among high school students since 2005, and middle school
students since 2011. However, they found increased edible use, 27.8% to 35.6%, from
2015 to 2017 (Retail Marijuana Public Health Advisory Committee, 2018). Additional
trends demonstrate increases in marijuana-related emergency department visits especially
among adolescents ages 12-17, increases in hospital admissions where patients received a
marijuana related substance use disorder diagnosis, increases in marijuana exposure
poison center calls, and a significant increase (tripling between 1999 and 2010) in
marijuana metabolites in the blood of fatal accident drivers (Brady & Li, 2014; Davis,
Mendelson et al., 2016; Wang et al., 2017; Zhu & Wu, 2016).
Defining Marijuana and Methods of Ingestion
Marijuana refers to the dried leaves, flowers, stems, and seeds harvested from the
Cannabis sativa or Cannabis indica plant. Delta-9-tetrahydrocannabinol (THC) is the
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primary proactive ingredient in marijuana (National Institute on Drug Abuse, 2018). This
ingredient is what gives marijuana its mind-altering effects, and what makes it attractive
to users because this effect can function as a reinforcer. The reinforcing effects of THC
are mediated by cannabinoid CB1 receptor through the activation of the mesolimbic
dopamine system, otherwise known as the brain’s reward system which mediates a range
of reinforcing stimuli (Cooper & Haney, 2009). The strength of the desirable or mindaltering effect is determined by multiple factors including the dose or potency as well as
the method of ingestion used (Budney & Borodovsky, 2017). Marijuana with higher
levels of THC generally delivers higher levels of the desirable or mind-altering effects
than lower potency marijuana. Therefore, marijuana users are more likely to ingest higher
potency marijuana, because of its higher reinforcing effects. Higher potency marijuana
can increase the chances of cannabinoid-induced behavior and physiological dependence
(Cooper & Haney, 2009; Cooper & Haney, 2009b). Average potency for flower samples
in the state of Colorado in 2017 was 19.6%, while for concentrate products the potency
was on average 68.6%. Of note, there were some outlier concentrate products with
potency at 90% or above (Orens, Light, Lewandowski, Rowberry, & Saloga, 2018).
In addition to dose/potency, the method of marijuana ingestion contributes to the
level of intoxication of the marijuana user (see Table 2 for a summary of the speed of and
length of intoxication effect for each method of ingestion; Abrams et al., 2007; Corral,
2001; Huestis, 2007; Huestis, Henningfield, & Cone, 1992; Isbell et al., 1967;
Lemberger, Crabtree, & Rowe, 1972; Perez-Reyes et al., 1973). Marijuana can be
administered via smoking, vaping, dabbing, orally, and sublingually/topically and these
methods of ingestion have been changing rapidly in the new legalization climate. Product
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diversity may be partially influenced by marijuana dispensaries, or retail stores, that are
motivated to increase sales through increasing the variety of products available to
consumers (Borodovsky et al., 2016; Pacula et al., 2014; Pacula et al., 2015).
Table 2
Speed of intoxication and length of intoxication effect
Method of Ingestion Speed of Intoxication
Smoking
Vaping
Dabbing
Oral
Topical

Immediate
Immediate
Immediate
Delayed
**

Length of Effects

1 to 4 hours
1 to 4 hours
1-2 hours strong, then 3-4 medium
Over 6 hours*
**

Note: *depending on the dose ingested; **no information available
When smoking marijuana, one uses small pipes, joints, blunts, or water pipes to
inhale smoke created from the burning of the flower form of marijuana. The effects of
smoking marijuana can be felt almost immediately as the THC passes from the lungs
directly to the blood stream, which then carries the chemical to the brain (National
Institute on Drug Abuse, 2018). These effects last approximately 1 to 4 hours (Huestis et
al., 1992). Smoking marijuana also produces negative or undesirable effects, including
the delivery of known carcinogens into the body and numerous alterations in lung
functioning (Tashkin et al., 2002).
Marijuana can also be ingested by using electronic-cigarettes (e-cigarettes) and
other vaping devices. These devices heat liquid (often in cartridge form) or solid
preparations of marijuana and other substances to create a smokeless vapor with
psychoactive compounds (e.g. nicotine, THC) that the user inhales. When vaping, the
effects of the ingested marijuana can be felt immediately, similar to smoking marijuana,
and it has a similar duration (Abrams et al., 2007). Vaping reduces carcinogenic toxins
that are typically consumed when inhaling combustible marijuana and tobacco smoke
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because one is inhaling the vapors, rather than the actual smoke (Van Dam & Earleywine,
2010). Vaping has been perceived as a healthier alternative and less risky than traditional
methods of consuming tobacco and marijuana (Camenga et al., 2015). However, as
discussed below, recent research has shown that many patterns of lung injury have been
reported with vaping (Henry et al., 2020).
Dab(s) is a colloquial term that refers to a more concentrated form of marijuana,
butane hash oil (BHO). BHO is created through the extraction of THC using butane as a
solvent from the flower form of marijuana (Meier, 2017). This form resembles a hard,
wax-like concentrate. BHOs can reach THC levels anywhere from 70% to 90%,
compared to flower forms which have ranges that are nearly 10 times lower. “Dabbing”
is the term used to describe the ingestion of BHO, while “dab” is the oil/wax placed on a
heated glass or titanium rod (as part of a “dab rig”), typically heated with a blow torch.
This vaporizes the substance, allowing the user to inhale the vapors (Loflin &
Earleywine, 2014). This method of marijuana ingestion also has similar effects to
smoking in regard to how quickly the effect is felt, however, the effects of this method
are typically much stronger and remain stronger longer due to the higher levels of THC.
Morean, Kong, Camenga, Cavallo, and Krishnan-Sarin (2015) found that adolescents
who vape marijuana most often use highly potent oil, wax, or liquid preparations.
Edibles refer to marijuana infused products that one is able to ingest orally. These
can include products such as baked goods, drinks, and candy. The effects of this method
of ingestion can be delayed in comparison to smoking and vaping. Often, the effects may
not be felt for 30 minutes to an hour, because it must first be digested. This method of
ingestion delivers less THC into the blood stream than smoking and vaping, however
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because of the delayed effect, individuals may consume more THC than intended which
can lead to unexpected highs (Allen et al., 2017; National Institute on Drug Abuse, 2018).
Additionally, the effects of orally ingesting marijuana can last over 6 hours depending on
the dose ingested (Lemberger et al., 1972). These products historically have been
frequently inaccurately labeled, with variable doses of marijuana’s proactive ingredient
THC (Vandrey et al., 2015). Most edible products currently in the market lack
empirically based packaging regulations, proactive ingredient levels, and safety standards
(Benjamin & Fossler, 2016; Cao, Srisuma, Bronstein, & Hoyte, 2016). In some states
where marijuana use is legal, there are laws in place to limit the attractiveness of edibles
to youth and require child-resistant packaging, due to increases in edible marijuana
overdoses among children and adolescents (Wang et al., 2016).
Another method of administration for marijuana is sublingually or topically. This
involves applying lotion, balm, a transdermal patch, oil, or spray to the skin. It appears
that many of these topical methods include cannabidiol (CBD), which is a type of
cannabinoid that tends to be non- or less-psychoactive compared to THC. One form of
CBD (Epidiolex) was recently approved by the Food and Drug Administration (FDA) for
medical use to treat two forms of severe epilepsy (Gottlieb, 2018; National Institute on
Drug Abuse, 2018b). However, since this is a rapidly developing method of
administration for marijuana, limited research is available regarding the many forms this
topical administration can take.
A body of evidence specific to recreational marijuana use is urgently needed to
guide, prioritize, and evaluate public health and policy efforts (Allen et al., 2017).
Regulatory processes in states that allow marijuana determine how products can be
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created, distributed, and accessed. These regulations can influence marijuana use age of
onset, frequency and quantity of use, as well as the progression to problematic marijuana
use (Budney & Borodovsky, 2017). The following review will provide the theoretical
background for a study that will examine current trends and associated problems related
to marijuana ingestion among young adult marijuana users.
Theoretical Background
As mentioned earlier, there is a high level of similarity in the median age of onset
for marijuana use (Degenhardt et al., 2008). This suggests that there may be similar paths
certain individuals take to their initiation of use, as well as potential development of
substance use problems. Mayes and Suchman (2006) have proposed a developmental
pathway to initiation of substance use among adolescents (Figure 1; added with
permission from Dr. Mayes), as well as the progression of substance use in adolescence
into dependence (Figure 2; added with permission from Dr. Mayes). These models
include many mechanisms that contribute along these paths and are associated with
greater likelihood of negative outcomes.
In Figure 1, a set of pathways leading to the initiation of substance use in
adolescence is shown. These pathways include individual as well as contextual factors.
They propose that genetic factors can mediate the initiation of substance use through the
individual development of emotional and behavioral capacities. This part of the model
draws from Bandura’s social cognitive theory of self-regulation (Bandura, 1991). Selfregulation and control are influenced by contextual factors such as family environment,
peers, and school. Mayes and Suchman (2006) state that as a child develops, these prior
experiences (e.g. individual development, effect of contextual factors) can lead to
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positive or negative adaptations to their environment. They propose that as a child enters
adolescence, their peers influence on substance initiation can be strongest and the
availability of a drug can shift an adolescent away or towards drug initiation (Mayes &
Suchman, 2006).

Figure 1. Model for initiation of substance use in adolescence
Note: From Mayes and Suchman (2006, p. 611)
Mayes and Suchman (2006) also proposed a second developmental pathway
model for the progression to substance dependence/addiction (see Figure 2). Similar to
the first model, this model includes many individual factors (e.g., genetics, psychosocial)
and some contextual factors (e.g. peers, school) on the path to substance dependence.
Mayes and Suchman state that from initial use, there are multiple mediating factors that
can increase or decrease an individual’s likelihood of developing substance dependence.
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These initial mediating factors include genetic vulnerability for addiction as well as mood
disorders, in addition to problem behaviors. From these initial mediating factors,
contextual factors such as peer/school influence an individuals’ path to substance
dependence. Compared to the first model, this model has a limited number of
components that draw from the social cognitive theory. More credence could be given in
this model to an individual’s self-development across many of the factors included,
through their self-regulation of their motivation and actions which can contribute to the
development of substance use disorders (Bandura, 1991; Mayes & Suchman, 2006).

Figure 2. Model for the progression to substance use and dependence
Note: From Mayes and Suchman (2006, p. 613)
Both of these models presented by Mayes and Suchman (2006) are multilevel
approaches that consider individual (e.g. genetic vulnerability, emotional regulation) and
contextual factors (e.g. peers, family, school) that can lead an individual to initiation of
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substances in adolescence, and continued drug use leading to substance dependence. In
the first model, the present study will expand upon the contextual factors considered as
well as include method of ingestion as a possible influence on initiation of substance use
(see Figure 3; adapted with permission from Dr. Mayes). Mayes and Suchman (2006)
included availability of drugs in their model, however, it is important to consider legal
status, price, and awareness of substances. Furthermore, the availability of certain
methods of ingestion needs to be considered as a possible mechanism that can contribute
to initiation of substance use. In the second model, the multilevel approach considers
individual (e.g., genetic vulnerability, problem behavior) and some contextual (e.g.,
peers, school) factors in the development of substance use disorders; however, more
information needs to be included regarding contextual factors as well as methods of
ingestion (McCrory & Mayes, 2015). Similar to the adaptations in the first model, this
study will expand upon the continued influence of additional contextual factors, as well
as explore the effects methods of ingestion may have on trajectories leading to substance
dependence (see Figure 4; adapted with permission from Dr. Mayes). With the rise of
legalization of marijuana across the United States, contextual factors and an
understanding of the effects of method of marijuana ingestion become an increasingly
vital components in this multilevel approach to research.
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Figure 3. Adapted model for the initiation of substance use in adolescence
Note: Adapted from Mayes and Suchman (2006, p. 611)

Figure 4. Adapted model for the progression to substance use and dependence
Note: Adapted from Mayes and Suchman (2006, p. 613)
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The proposed study described in the following paragraphs will highlight the
importance of exploring how methods of ingestion and additional contextual factors
within these developmental pathway models influence drug use initiation and addiction.
It is important for researchers to consider all factors that can influence these paths. By
continuing to increase the research based on these factors, prevention and intervention
programs can continue to be tailored and improved.
Associations of Marijuana Use
A multitude of adverse consequences of marijuana use have been identified in
previous research, including both short- and long-term effects. The negative
consequences cover a range of areas of functioning including health, education,
psychosocial functioning, and employment status (Hall & Degenhardt, 2015; Rigucci et
al., 2016; Volkow et al., 2014).
Short Term Health Effects
Marijuana use results in acute impairments in both memory and attention. These
impairments can persist and worsen with increasing years of regular use and early
initiation (Solowij et al., 2002; Tapert et al., 2008). Acute effects of anxiety, panic
reaction, and psychotic symptoms have been reported, especially by first time users (Hall
& Pacula, 2003; Kalant, 2004). Deficits in motor coordination have also been noted as an
acute effect of marijuana use. Marijuana users have been noted to have higher rates of
hospitalization for all causes of injury than non-users (Gerberich et al., 2003).
Marijuana has been implicated in increasing the risk of injury or fatality while
driving (Hall & Pacula, 2003; Hall, Renström, & Poznyak, 2016). According to Brady
and Li (2014), marijuana is the most frequently reported illicit drug in connection with

27
impaired driving and accidents. Marijuana use results in deficits in motor, cognitive, and
behavioral performance that can increase accident risk (Ramaekers, Berghaus, van Laar,
& Drummer, 2004; Rogeberg & Elvik, 2016), with the effects becoming more marked
with increases in THC dose. Research suggests that using marijuana before driving
increases accident risk by 2 to 3 times (Ramaekers et al., 2004). Driving simulation
studies have found a relationship between driving performance and blood THC
concentration (Lenné et al., 2010), with recent smoking and blood concentration levels of
2 to 5 ng per milliliter being associated with substantial impairment (Hartman & Huestis,
2013). The risk of injury and fatality crashes is further increased because of a link
between marijuana use and failure to use seatbelts (Liu, Huang, & Pressley, 2016).
New research that has been emerging has highlighted a relationship between ecigarette/vaping devices and acute, severe respiratory distress. Many patterns of lung
injury, including multiple forms of pneumonia and hemorrhaging hypersensitivity
pneumonitis, diffuse alveolar hemorrhage, acute lung injury and acute eosinophilic
pneumonia, organizing pneumonia, lipoid pneumonia, as well aa giant cell interstitial
pneumonia, have been associated with vaping (Henry et al., 2020). The Centers for
Disease Control and Prevention (CDC; 2020) has termed the syndrome e-cigarette, or
vaping, product use-associated lung injury (EVALI). As of February 18, 2020, the CDC
reported a total of 2,807 patients hospitalized with EVALI, with reports from all 50 states
and the District of Columbia. Sixty-eight deaths have been confirmed across the United
States as a result of EVALI (CDC, 2020). The majority (82%) of individuals who vaped
and experienced EVALI reported having used products with THC or CBD, with 33% of
them using exclusively THC containing products. Fifty-seven percent of the EVALI
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patients reported using nicotine-containing products, with 14% reporting exclusive use of
nicotine-containing products (CDC, 2020).
Long Term Health Effects of Chronic Use
One of the most well-known long-term effects of chronic marijuana use is
Cannabis Use Disorder (CUD; formerly called Marijuana Abuse/Dependence). CUD is
characterized by biopsychosocial impairments that increase in severity with frequent and
heavy use (Hasin et al., 2013; Hasin et al., 2015; Sherva et al., 2016). Rates of CUD have
increased over the last decade, especially in states with legalized marijuana (Hasin et al.,
2015; Hasin et al., 2017; Wen et al., 2015). Studies have reported that the risk of
dependence is around 9% for those who have ever used marijuana, with increases to one
in six for those who initiate use in adolescence (Anthony, Warner, & Kessler, 1994; Chen
et al., 2009; King & Chassin, 2007; Lopez-Quintero et al., 2011; Volkow et al., 2014),
and 25 to 50% for daily users (Hall & Degenhardt, 2009; Hall & Pacula, 2003; van der
Pol et al., 2013). Chen and colleagues (2009) reported that those who initiate in
adolescence are 2 to 4 times more likely to report symptoms of marijuana dependence
within 2 years after initiation. Additional research found that 19.5% of lifetime marijuana
users meet criteria for DSM-5 CUD, with 23% who were symptomatically severe, of
these 48% were not functioning in major roles (e.g., work; Hasin et al., 2016). Multiple
studies have shown that higher potency products can increase the probability of
experiencing desirable effects from marijuana use. Higher potency products (e.g.,
concentrates) paired with methods that can be considered less harmful (e.g. less
carcinogens), could facilitate easier paths to escalating and problematic use patterns
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(Agrawal et al., 2006; Cooper & Haney, 2009; Fergusson, Horwood, Lynskey, &
Madden, 2003).
Tolerance and withdrawal symptoms are commonly reported with long term use.
Marijuana users can develop a tolerance to the effects of THC, which leads to increased
dose, frequency, or potency to reach the same desired effect (Maldonado, 2002).
Withdrawal symptoms typically occur when one stops or cuts back on their marijuana use
(Budney & Hughes, 2006; Kouri & Pope, 2000) and can be reversed with the ingestion of
THC (Budney & Hughes, 2006; Budney, Vandrey, Hughes, Thostenson, & Bursac, 2008;
Lichtman, Fisher, & Martin, 2001). Typical withdrawal symptoms include sleep
difficulty, restlessness, physical symptoms such as shakiness or tremors, sweating, fever,
chills, and headaches, decreased mood and appetite, in addition to increased irritability,
anger, anxiety or nervousness, and depression (Budney & Hughes, 2006; Karila et al.,
2014; Katz et al., 2014; Kouri & Pope, 2000). Individuals who experience withdrawal
symptoms typically experience a functional impairment of normal daily activities (Allsop
et al., 2012; Davis, Smith et al., 2016; Karila et al., 2014; Katz et al., 2014;). Typically,
withdrawal symptoms occur 1 to 2 days after an individual has stopped heavy use. They
are most intense during the first week of abstinence, with effects that can persist as long
as a month (Budney et al., 2003; Copersino et al., 2006; Davis, Smith et al., 2016;
Elkashef et al., 2008; Hall et al., 2016; Kouri & Pope, 2000; Milin, Manion, Dare, &
Walker, 2008).
Marijuana use has also been found to have long-term effects on physical health.
Additional research on the health effects of marijuana has found that regular marijuana
smokers report more symptoms of chronic bronchitis than non-smokers (Tashkin et al.,
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2002; see Tetrault et al., 2007 for a review). It has been reported that immunological
competence is also impaired by marijuana use, increasing risks for respiratory infections
and pneumonia (Owen et al., 2014; Tashkin et al., 2002). Marijuana use has been
associated with inflammation of airways, airway resistance, and lung hyperinflation in
regular heavy users, but not infrequent users (Pletcher, et al., 2012; Tashkin, 2013).
Cancer risk for marijuana users has been implicated, but research has not
consistently reported an association. It is possible that marijuana use may cause cancers
due to containing the same carcinogen, at higher levels, as tobacco smoke (Callaghan,
Allebeck, & Sidorchuk, 2014; Hashibe et al., 2005), however evidence has suggested risk
of cancer is lower with marijuana than with tobacco (Hashibe et al., 2006). Marijuana has
also been implicated with cardiovascular risks, with research showing association with
vascular conditions that increase the risk of myocardial infarction (Mittleman, Lewis,
Maclure, Sherwood, & Muller, 2001), stroke, and transient ischemic attacks during
marijuana intoxication (Thomas, Kloner, & Rezkalla, 2014) due to THC producing a
dose-related increase in heart rate (Jones, 2002).
Research has consistently shown deficits in verbal learning, memory, and
attention in regular marijuana users (Solowij et al., 2002; Solowij & Pesa, 2012; see
Crane et al., 2013 and Solowij & Battisti, 2008 for reviews). Marijuana has been shown
to impair the neural connectivity of the precuneus, which is involved in functions such as
alertness and awareness, and the fimbria, which is an area in the hippocampus important
in learning and memory (see Broyd et al., 2016 for a review; Zalesky et al., 2012). It has
been found to affect certain subcortical networks, specifically those that process habits
and routines (Filbey & Yezhuvath, 2013). Marijuana use has also been associated with
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reduced functional connectivity in the prefrontal networks responsible for executive
functioning (e.g. inhibitory control and working memory; Renard et al., 2016). Renard
and colleagues (2016) found chronic marijuana use altered the prefrontal cortex (PFC)
structure and impaired cortical synaptic plasticity in the hippocampus-PFC circuit, and
imaging studies have shown deceased activity in the prefrontal regions and reduced
volumes in the hippocampus (Batalla et al., 2013). Furthermore, past work has found an
association between frequent use of marijuana from adolescence into adulthood and
significant declines in IQ, with effect sizes ranging from -.11 to -.038 (a loss equivalent
up to approximately 6 IQ points; Meier et al., 2012).
Research has also consistently shown that deficits in cognitive functioning and
changes to brain structures are related to the duration and frequency of marijuana use (a
dose-dependent response), the age of initiation, and the estimated cumulative dose of
THC (Solowij et al., 2002; Solowij & Pesa, 2012; see Crane et al., 2013 and Solowij &
Battisti, 2008 for reviews). In other words, the negative effect of marijuana on cognition
and functional connectivity of the brain is increasingly prominent if use starts in
adolescence and is regular or chronic and heavy (Zalesky et al., 2012). These findings are
consistent with preclinical findings that indicate the cannabinoid systems play a
prominent role in synapse formation during brain development and can be impaired with
exposure to marijuana in adolescence (Gaffuri, Ladarre, & Lenkei, 2012).
Psychosocial Effects of Marijuana Use
Marijuana has been associated with poor educational attainment among school
children (see Lynskey & Hall, 2000 for a review; Degenhardt, Hall, & Lynskey, 2001;
Ellickson, Tucker, Klein, & Saner, 2004; Fergusson, Boden, & Horwood, 2015; Volkow
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et al., 2014). Early marijuana use has been associated with impaired performance in
school, increased risk of dropping out of school, in addition to lower chances of pursuing
post-secondary training (Bray, Zarkin, Ringwalt, & Qi, 2000; Horwood et al., 2010;
Lynskey & Hall, 2000; Meier et al., 2012). Ellickson, Bui, Bell, and McGuigan (1998)
found that marijuana use before the age of 15 was related to dropping out of high school,
even after adjusting for confounding variables. As noted earlier, marijuana use beginning
in adolescence is related to cognitive impairments (Meier et al., 2012), which can lead to
failure to learn in school and interfere with the capacity to achieve educational goals.
This leads to poor grades and possibly dropping out of school (Lynskey & Hall, 2000).
Across multiple cross-sectional (Compton, Gfroerer, Conway, & Finger, 2014;
Cunradi, Ames, & Xiao, 2014; De Simone, 2002) and longitudinal studies (Fergusson &
Boden, 2008) that have adjusted for sociodemographic characteristics, marijuana use has
been associated with negative employment outcomes. Specifically, marijuana use has
been associated with future job loss (Compton et al., 2014), reduced likelihood of
employment (Cunradi et al., 2014), and difficulties at work (Degenhardt et al., 2001).
Fergusson and Boden (2008) found that increasing levels of marijuana use from ages 14
to 21 was related to higher unemployment at data points between ages 21 and 25. Heavy
marijuana use has also been associated with lower income, and greater need for
socioeconomic assistance (Brook, Lee, Finch, Seltzer, & Brook, 2013; Fergusson &
Boden, 2008).
Research conducted in a number of countries has shown that early marijuana use
can predict increased risk of using other illicit drugs, even though not all who use
marijuana go on to use heavy drugs (Agrawal et al., 2004; Hall & Degenhardt, 2007;
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Swift et al., 2012). Swift and colleagues (2012) found those who reported weekly and
daily marijuana use were consistently reporting amphetamine, cocaine, and ecstasy use at
two to three times the rate of those who reported occasional use of marijuana. The order
in which the illicit drugs are used aligns with the prevalence of different types of illicit
drugs used in the adult population of the country (Degenhardt et al., 2010). Twin studies
have shown that a twin who uses marijuana before age 17 is more likely to have used
sedatives, hallucinogens, stimulants, and opioids than a twin who did not use marijuana
(Ellickson, D’Amico, Collins, & Klein, 2005; Ellickson, Tucker et al., 2004; Lynskey et
al., 2003).
Marijuana Use and Mental Health
Long-term research on adolescent marijuana users has shown they report greater
negative emotionality than healthy controls between the ages of 13 and 23 (Heitzeg et al.,
2015). Moreover, this negative emotionality remained elevated rather than decreasing
with age as in the healthy controls. Chronic marijuana use has also been associated with
both blunted and hyperactive stress responses (Cuttler et al., 2017). Cuttler et al. (2017)
found healthy controls had increases in cortisol levels under a stress-provoking situation,
however, the same increase was not found in active marijuana users.
Regular marijuana use has been associated with increased risk of anxiety and
depression (Patton et al., 2002), although the literature is mixed, as well as lower
satisfaction with life (Brook et al., 2013; Fergusson & Boden, 2008). Moore et al. (2007)
completed a meta-analysis on the relationship between marijuana use, anxiety, and
depression. Outcomes across included studies were not consistent, with marijuana
resulting in a modest association; however, many studies did not adequately control for

34
confounding variables. Research has found that adolescents undergoing treatment for
withdrawal symptoms from marijuana had at least one comorbid diagnosis of anxiety or
depression and greater marijuana use was associated with increased depressive and
anxiety-like symptoms (Dorard, Berthoz, Phan, Corcos, & Bungener, 2008). Genetic
studies have found CUD shared genetic risk with depression (Carey et al., 2016; Sherva
et al., 2016). Additional genetic research suggests common causes underlying the
comorbidity between CUD and depression (Hodgson et al., 2016), or a causal effect of
CUD on depression (Smolkina et al., 2017). Henquet, Krabbendam, de Graaf, ten Have,
and van Os (2006) found marijuana use at baseline predicted increased risk of manic
symptoms in patients diagnosed with bipolar disorder in a 3-year follow-up. Clinical
studies have found individuals diagnosed with bipolar disorder who continue to use
marijuana have increased frequencies of manic episodes and are less satisfied with their
lives than those who do not use marijuana (Silberberg, Castle, & Koethe, 2012).
Marijuana use has been associated with psychotic symptoms as well as psychotic
disorders, especially among individuals with a preexisting genetic vulnerability (Brook,
Brook, Zhang, Cohen, & Whiteman, 2002; Caspi et al., 2005; Charilaou et al., 2017;
Hall, 2009; Volkow et al., 2014). A meta-analysis of longitudinal research looking into
the relationship between psychotic symptoms and marijuana found that the relationship
between psychotic symptoms or psychotic disorders among those who had used
marijuana was higher in regular users, with a dose-response relationship between
frequency of use and risk for developing psychotic symptoms or a psychotic disorder
(Moore et al., 2007). Another meta-analysis showed that individuals who were at high
risk for psychosis had higher rates of marijuana use and CUD, as well as higher rates of
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positive psychotic symptoms (e.g., unusual thought content, suspiciousness; Carney,
Cotter, Firth, Bradshaw, & Yung, 2017). Heavier marijuana use, greater drug potency,
and early initiation have all been found to negatively affect the disease trajectory through
earlier than average age of first-episode psychosis (i.e., by advancing the time of a first
psychotic episode by 2 to 6 years; Di Forti et al., 2013; Large, Sharma, Compton, Slade,
& Nielssen, 2011).
Research into the associations between self-harm, suicidal ideation, suicide
attempts, and marijuana use has been inconclusive. More than weekly marijuana use was
associated with increased likelihood of reporting suicidal ideation, but only in males (van
Ours, Williams, Fergusson, & Horwood, 2012). In contrast, another study found that
marijuana was associated with self-harm only in females (Patton et al., 1997).
Motives for Use
Negative outcomes related to marijuana use often vary person to person.
Similarly, marijuana users often report a range of reasons, or motives, for using
marijuana. Past studies have shown that certain motives are related to increased risks
across many psychosocial factors. It is possible that motives for using may also differ
based on the method of ingestion used. Much of the past work on motives for using
marijuana has focused on delineating these motives, as well as how they vary both
between and within individuals (Bonn-Miller, Zvolensky, & Bernstein, 2007). Some of
the more common motives found to be significant in research are coping,
experimentation, and social motives. Studies have found that coping, enhancement,
social, enjoyment, boredom, altered perception, relative low-risk, sleep/rest, and
expansion motives for use are associated with increased frequency of marijuana use
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(Bonn-Miller et al., 2007; Lee, Neighbors, Hendershot, & Grossbard, 2009). A study by
Bonn-Miller and Zvolensky (2009) found associations between marijuana dependence
and higher motivation to use marijuana for multiple reasons including enhancement,
conformity, and coping. A more recent study found greater endorsement of using
marijuana to cope to be associated with greater problematic use (Phillips, Lalonde,
Phillips, & Schneider, 2017). Lee and colleagues (2009) also found experimentation and
availability motives for use to be associated with less use. Davis, Arterberry, Bonar,
Bohnert, and Walton (2018) found conformity and passion motives to be associated with
greater frequency of use. This finding is unique in that it highlights the importance of
assessing passion for marijuana use, as obsessive passion has been shown to predict
frequency of use and related consequences. These studies evaluated the relationship
between marijuana use motives, frequencies of use, and problematic use; however, none
of these studies addressed the relationship of use motives with methods of ingestion.
Undoubtedly, marijuana has been associated with a plethora of negative effects
and outcomes both in the short- and long-term. Unfortunately, a major limitation of these
studies is that chronic heavy or regular marijuana users differ from non-users in a variety
of ways that are reflected through baseline differences (e.g., more likely to use alcohol,
differ in risk-taking behaviors; Hall, 2015). So, while it has been noted marijuana is
associated with many negative outcomes, causal evidence is lacking. Furthermore, a
number of the negative outcomes mentioned above noted increased negative effects as
the frequency of marijuana increased but have failed to assess the role method of
ingestion may have had in those increased negative effects (e.g. Agrawal et al., 2006;
Cooper & Haney, 2009; Fergusson et al., 2003; Solowij et al., 2002; Tapert et al., 2008).
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Additional research is needed to see if methods of marijuana ingestion are associated
with frequency of use, problematic use, motives for use, and general mental health
ratings, in the current legalization climate with increasingly diversified methods of
ingestion.
Patterns/Trajectories of Marijuana Use
Understanding the factors involved in long-term marijuana use can help delineate
youth who will initiate, experiment, and remain stable low users or phase out of
substance use altogether versus the small proportion of youth who will escalate to regular
and heavy use. This research is important as it can lead to targeted prevention and
intervention strategies for substance use disorders (Scalco & Colder, 2017). Research
using group-based developmental trajectory methods has shown considerable
heterogeneity within populations in longitudinal patterns of substance use, where
subgroups can be defined through patterns in timing, magnitude, and duration of risk
(Kosty et al., 2016; Scholes-Balog et al., 2016). These developmental trajectories are able
to identify the subgroups of youth who increase the frequency of their use over time and
escalate from more infrequent users to regular and chronic, heavy users. This information
can be used to provide targets for direct and intense prevention and intervention efforts.
Studies historically have found between three and seven developmental trajectory
patterns of marijuana use from adolescence to adulthood (e.g. Homel et al., 2014;
Schulenberg et al., 2005; Terry-McElrath et al., 2017; Windle & Wiesner, 2004).
Previous research on developmental trajectories will be discussed to outline past findings
and the associated risk factors to relate this work to changes in methods of ingestion.
Though select studies are highlighted below, a summary of this research, including the
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age and number of participants, years followed, number of classes, and class descriptions,
can be found in Table 3.
Developmental Trajectories
Three developmental trajectory groups have been identified in numerous studies.
Non-users, early users, and late onset users were identified in two separate studies
following participants from adolescents until young adulthood (Flory et al., 2004;
Scholes-Balog et al., 2016). In another study, trajectory groups of abstainers, occasional
users, and frequent users were identified in a cohort followed from adolescence until
young adulthood (Homel et al., 2014). Kosty and colleagues (2016) followed participants
from adolescence until adulthood and classified participants into the classes of persistent
increasing risk, maturing out with increasing risk then decreasing risk, and stable low
risk.
Two studies have identified four trajectory groups. Following participants from
early adolescence until young adulthood, Scalco and Colder (2017) identified classes
consisting of: non-users, experimenters, early initiator-increasing users, and sharp
increasing users. Four developmental trajectories were also found following a sample of
students from early adolescence until adulthood. The trajectories were early onset with
heavy use that decreased with age, light but persistent use, steady increase from age 13 to
23, and occasional use (Ellickson, Martino et al., 2004).
Five developmental trajectories have been identified by three separate studies.
Passarotti and colleagues (2015) followed adolescents over 6 years. They revealed nonusers, three trajectory classes of non-escalating users (low users, medium users, and high
users) as well as one escalating user trajectory. Another study that followed participants
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from early adolescence to early midlife found the trajectory groups of chronic
users/decreasers, quitters, increasing users, chronic occasional users, and
nonusers/experimenters (Zhang, Brook, Leukefeld, & Brook, 2016). Windle and Wiesner
(2004) followed high school students through early adulthood, and found five
developmental trajectory groups – high chronic, increasers, decreasers, experimental
users, and abstainers.
Additionally, three studies have identified six to seven trajectory classes.
Participants followed from mean age 14 until mean age 43 by Brook and colleagues
(2016) resulted in six developmental trajectory classes of marijuana use: chronic/heavy
users, increasing users, chronic/occasional users, decreasers, quitters, and
nonusers/experimenters. Using data from the Monitoring the Future Study, Schulenberg
et al. (2005) examined high school seniors through age 24 to understand developmental
trajectories. In this study, six trajectory groups were delineated: chronic, decreased,
increased, fling, rare, and abstain. Finally, Terry-McElrath and colleagues (2017)
followed participants from high school to age 50 and found seven developmental
trajectories of marijuana use. The trajectories were: non-users, two shorter-term use
classes, and four classes with longer-term moderate or heavy use.
Across these studies, 5-28% of those who initiated marijuana use escalated to
monthly or more frequent use (e.g., Schulenberg et al., 2005; Terry-McElrath et al.,
2017). Furthermore, many of these studies found that early, high level marijuana users
had less favorable outcomes compared to other, lower use trajectory groups (e.g.
Ellickson, Martino et al., 2004; Homel et al., 2014; Terry-McElrath et al., 2017). The
transition to high school seems to be a period of high risk for marijuana initiation, and
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early initiation is followed by divergent trajectories over time, meaning the relationship
between initiation and escalation is complex (Scalco & Colder, 2017). An understanding
of the risk factors associated with escalating heavy use is important to identify
adolescents who will benefit from more targeted intervention at an earlier age.
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Table 3
Summary of studies regarding patterns/trajectories of marijuana use
Study

N

Years
Followed
Ages 11-12
until 20-22

Number
of Classes
3

Flory et al.,
2004

481

Homel et al.,
2014

632

Ages 15
until 25

3

Kosty et al.,
2016

816

Ages 14
until 30

3

Scholes-Balog
et al., 2016

852

Ages 12
until 21

3

Ellickson,
Martino et al.,
2004

5,833

Age 13
until 29

4

Scalco &
Colder, 2017

755

Ages 11
until 18

4

Passarotti et al.,
2015

1,204

Ages 15
until 22

5

Windle &
Wiesner, 2004

1,205

Ages 15
until 23

5

Zhang et al.,
2016

548

Ages 1-10
until mean
age 43

5

Brook et al.,
2016

548

Ages 14
until 43

6

Class Descriptions (Percentage of
participants in each class)
Non-users (*)
Early Onset (*)
Late Onset (*)
Abstainers (31%)
Occasional Users (44%)
Frequent Users (25%)
Stable Low Risk (84%)
Maturing Out (9%)
Persistent Increasing Risk (7%)
Abstainers (62%)
Early Onset Users (11%)
Late Onset Occasional Users (27%)
Occasional Light Users (53%)
Early Light Users (5%)
Stable Light Users (17%)
Steady Increasers (25%)
Non-user (33%)
Experimenter (38%)
Early Initiator-Increasing (14%)
Sharp Increasing (15%)
Never/Non-Users (22%)
Low Users (29%)
Medium Users (24%)
High Users (8%)
Escalating Users (17%)
Abstainers (82%)
Experimental Users (9%)
Increasers (4%)
Decreasers (3%)
High Chronics (2%)
Nonusers/Experimenters (40%)
Chronic Occasional Users (26%)
Increasing Users (7%)
Quitters (19%)
Chronic Users/Decreasers (8%)
Nonusers/Experimenters (35%)
Quitters (22%)
Decreasers (14%)
Chronic/Occasional Users (20%)
Increasing Users (5%)
Chronic/Heavy Users (4%)
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Table 3, continued
Study

N

Schulenberg et
al., 2005

19,952

Terry-McElrath
et al., 2017

9,831

Years
Followed
Ages 18
until age
24

Number
of Classes
6

Ages 18
to 50

7

Class Descriptions (Percentage of
participants in each class)
Abstain (47%)
Rare (28%)
Fling (6%)
Decreased (7%)
Increased (5%)
Chronic (5%)
Non-Users (44%)
Early YA** Moderate Users (22%)
YA** Moderate Users (12%)
Persistent Moderate Users (6%)
Early YA** Heavy Users (6%)
YA** Heavy Users (5%)
Persistent Heavy Users (5%)

Note: * not reported by the study; ** YA = Young Adult
Risk Factors Associated with Chronic/Heavy
Use Developmental Trajectories
Research has shown certain risk factors are associated with chronic heavy or
increasing marijuana use from adolescence to young adulthood. Chronic heavy and
increasing marijuana users were distinguished from lower or non-users by demographic
variables such as: male gender (e.g. Ellickson, Martino et al., 2004; Juon, Fothergill,
Green, Doherty, & Ensminger, 2011; Silins et al., 2013; Terry-McElrath et al., 2017),
pubertal development at baseline (Scalco & Colder, 2017), low religious commitment
(Jackson, Sher, & Schulenberg, 2008; Silins et al., 2013; Terry-McElrath et al., 2017),
race/ethnicity with inconsistent results (Ellickson, Martino et al., 2004; Silins et al.,
2013), and marriage (Schulenberg et al., 2015; Staff et al., 2010). These distinguishing
variables also included factors related to individual as well as parental levels of education
including adolescent school performance or commitment (Flory et al., 2004; Passarotti et
al., 2015), not attending college (Nelson, Van Ryzin, & Dishion, 2015; Passarotti et al.,
2015), and higher parental education (Ellickson, Martino et al., 2004; Passarotti et al.,
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2015; Terry-McElrath et al., 2017). Peer influence, substance use, and delinquency were
also associated with chronic heavy and increasing trajectories (Ellickson, Martino et al.,
2004; Flory et al., 2004; Hix-Small et al., 2004; Passarotti et al., 2015; Scalco & Colder,
2017). Finally, a number of psychological and personality factors have been identified in
more heavy users, including emotional dysregulation (Brook et al., 2016), aggressive and
antisocial behavior (Passarotti et al., 2015), conduct problems (Ellickson, Martino et al.,
2004; Flory et al., 2004; Hix-Small et al., 2004; Scalco & Colder, 2017; Windle &
Wiesner, 2004), psychiatric disorders (Flory et al., 2004; Windle & Wiesner, 2004),
temperament (Scalco & Colder, 2017), novelty seeking (Brook et al., 2016; Ellickson,
Martino et al., 2004; Flory et al., 2004; Hix-Small et al., 2004; Passarotti et al., 2015),
and co-morbid substance use (Brook et al., 2016; Jackson et al., 2008; Passarotti et al.,
2015; Silins et al., 2013; Terry-McElrath et al., 2017). Many important risk factors have
been identified, however, no studies to date have sought to understand if method of
ingestion could be a risk factor for chronic heavy or escalating use.
Research on the longitudinal course or pattern of marijuana use is an area that is
currently growing. With increasing social acceptance and legalization of marijuana in the
United States today, it is likely that the age of onset could become increasingly younger
and these developmental trajectories could change. Continued understanding of patterns
of marijuana use during adolescence and emerging adulthood is needed, specifically in
terms of why some abstain, maintain low levels, escalate their use over time, or
decrease/quit their use altogether. Risk factors for heavy use developmental trajectories
have been discovered in the research, however, there are still risk factors that need to be
investigated. In this continually changing legal climate, method of marijuana ingestion is
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a critical area to research as it is quickly changing. Information about patterns of
marijuana use frequency, quantity, and method of ingestion, particularly among emerging
adults, is needed to improve understanding of health consequences related to marijuana
use and for public health planning (Tucker, Ellickson, Orlando, Martino, & Klein, 2005).
In addition to increasing the understanding of the frequency of marijuana use in
developmental trajectories it will be important to also consider transitions in method of
ingestion. Often times we think about how individuals move across substances, starting
with tobacco and alcohol, and perhaps to illicit drugs. However, the transitions within a
specific type of drug have been studied less, specifically for illicit drugs and methods of
use within a specific type of drug. The developmental trajectory research presented
earlier assessed marijuana use from early adolescence until adulthood. In that time, many
transitions in methods of ingestion could occur for various reasons and coincide with
increases in the frequency of marijuana use. Some of these reasons could be related to
availability, perceptions, as well as context. This information is important for increasing
knowledge about marijuana use, especially as the legal status of marijuana in the United
States is shifting and the availability of methods is increasing.
Contextual Factors
The availability, or ease/difficulty of accessing a substance, has many influences
on individuals as well as the population as a whole. Availability of a substance can be
affected by many different factors, including the monetary price or cost of the product as
well as the amount of effort and time required to obtain the product. The increasing
number of states that have legalized medicinal and recreational marijuana has likely
affected these factors. Mair, Freisthler, Ponicki, and Gaidus (2015) found the addition of
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one dispensary per square mile was cross-sectionally associated with a 6.8% increase in
marijuana hospitalizations with a marijuana abuse/dependence code. This study is one
example of how contextual factors (e.g. price, availability) can affect marijuana use.
Additional studies in key contextual areas are outlined below.
Monetary Price
The changing legal status of marijuana in the United States has had an effect on
the monetary price of marijuana. Research has shown that there have been substantial
decreases in the price of marijuana when compared to its pre-legalization cost (Caulkins
et al., 2011; Hall & Lynskey, 2016). Past research on alcohol and tobacco has shown a
clear relationship between the price of the product and frequency of use across
populations (Chaloupka, Cummings, Morley, & Horan, 2002; Chaloupka, Straif, & Leon,
2011; Pacula et al., 2014). Since each state is responsible for drafting laws and
regulations regarding marijuana, tax rates, manufacturing sales, and purchase levels will
need to be considered individually for each state (Budney & Borodovsky, 2017). The
aforementioned factors will need to be regulated while also considering how black
markets related to marijuana will change in response to these factors (Caulkins et al.,
2011).
Ease of Access
The regulations that have been passed by states regarding marijuana use are
highly variable, with many different provisions. Currently, some states provide access to
marijuana through retail stores or medical dispensaries. Due to the variations in
marijuana regulation laws, some states permit a limited number of medical dispensaries
(e.g. Connecticut), while others permit much larger numbers (e.g. Colorado). Larger
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numbers of outlets available to purchase marijuana can lead to higher availability through
lowering consumer travel time and cost of transportation (Budney & Borodovsky, 2017).
Borodovsky and colleagues (2016, 2017) found longer periods of marijuana legalization
and higher marijuana outlet (recreational and medical) density were related to higher
likelihood of lifetime vaping and edible use for youth ages 14 to 18 in states with legal
recreational marijuana use as well as adults in states with legal medicinal marijuana use.
In fact, they found that higher marijuana outlet density was associated with younger age
of onset of vaping in addition to doubling the likelihood of youth trying vaping and
tripling the likelihood of trying edibles. Of 634 adults who were past-year marijuana
users in Colorado, 70% tried a new marijuana or hashish product during the first year that
recreational marijuana was legal in Colorado (Allen et al., 2017). In this study, trying
new products the year after recreational marijuana was legalized in Colorado was
associated with greater odds of experiencing an unexpected high after controlling for
many variables including current use and amount of marijuana consumed in the past
month (Allen et al., 2017). The CDC reported that 50% of EVALI patients provided data
on the product source. Sixteen percent of the individuals reported acquiring products only
from commercial sources (recreational and/or medical dispensaries, vape or smoke shops,
stores, and pop-up shops), while 78% reported obtaining products from informal sources
(family/friends, dealers, online, or other sources). Six percent of individuals reported
acquiring products from both commercial and informal sources (Centers for Disease
Control and Prevention, 2020).
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Home Cultivation
Another way in which regulations can affect these factors is through provisions
that allow individuals to grow marijuana (“home cultivation”). Home cultivation provides
easier access to marijuana. While there may be policies regulating home cultivation in
states where marijuana is legal, home cultivation presents many challenges in terms of
enforcement as well as preventing excessive growth of marijuana (Budney &
Borodovsky, 2017). Research on medical marijuana laws and their effect has found that
home cultivation was predictive of last month as well as heavy use (Pacula et al., 2015).
Borodovsky and colleagues (2017) also found home cultivation to be associated with
higher likelihood and younger age of onset of marijuana edible use among youth ages 14
to 18. Among persons ages 12 and older, higher percentages of participants were
reporting marijuana was easier to access. Participants also reported more frequently
buying and growing marijuana versus getting it for free and sharing it (Azofeifa et al.,
2016).
Awareness
In the last few years, research on the prevalence of marijuana information on
social media has been increasing. Studies analyzing tweets on Twitter have found
significantly greater numbers of tweets regarding edibles and dabs in states that allow
recreational and/or medical use of marijuana (Daniulaityte et al., 2015; Lamy et al., 2016;
Lamy et al., 2018), as well as pro-marijuana (i.e. plans to use, health benefits,
legalization) tweets among those younger than 20 years of age (Cavazos-Rehg et al.,
2015). Specifically, Lamy and colleagues (2018) found tweets regarding dabs to be
between seven and 16 times higher in states that allowed recreational use of marijuana
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versus states where it is illegal. Furthermore, they found the tweets regarding edibles to
be generally positive themed, while the tweets regarding dabs promoted it as a safe
method. Cavazos-Rehg, Zewdie, Krauss, and Sowles (2018) further analyzed tweets
regarding edibles and found that nearly half normalized marijuana use or plans to
consume. Individuals who promoted edibles were more likely to be between the ages of
17 and 24 years old. Another study (Cavazos-Rehg et al., 2016) that analyzed tweets
about high-potency marijuana found that common themes included discussions
surrounding intense high and/or extreme effects (i.e. physiological and psychological)
from dabbing (22%) as well as excessive/heavy dabbing (15%). Several studies have
examined YouTube videos on edibles and dabs. Overall, they demonstrated that such
information was easily accessible, and many videos provided educational information
(e.g. instructions, warnings; Krauss et al., 2015; Krauss, Sowles, Stelzer-Monahan,
Bierut, & Cavazos-Rehg, 2017). A study regarding marijuana related posts on Reddit
found the volume of posts on dabs increased significantly from 2010-2016 (Meacham,
Paul, & Ramo, 2018). These studies highlight a number of important points, including
how easy it is to access information on methods of marijuana ingestion, how younger
individuals tend to broadcast their use of certain methods through “posts” on social
media, as well as changing trends in volumes of posts related to certain methods of
ingestion.
As social acceptability and legalization of marijuana are shifting, availability and
awareness of different methods of ingestion are new areas of research that need to be
explored. Methods of marijuana ingestion in states where marijuana is legal are different
than those where it is currently illegal (Daniulaityte et al., 2015), and social media posts

49
regarding certain methods of ingestion have been changing over the years (Meacham et
al., 2018). Research is needed to identify emerging trends due to changing marijuana
legalization policies, to inform timely prevention and policy measures, and minimize
potential dangers of certain methods of use to consumers (Daniulaityte et al., 2015;
Gourdet et al., 2017; Schauer et al., 2016).
Reasons for Using Specific Methods of Ingestion
As increasing methods of marijuana ingestion become available, the reasons why
specific methods of ingestion are used or not used is becoming an increasingly important
question. These reasons could potentially effect population level statistics including age
of onset, frequency, and quantity of use. More evidence is necessary to guide regulatory
processes in states to determine how products can be created, distributed, and accessed to
ensure safety in regards new methods of use (Budney & Borodovsky, 2017).
In focus groups (N = 62) conducted in Denver, Colorado, and Seattle,
Washington, Giombi and colleagues (2018) found that edible marijuana users endorsed
many reasons for liking edibles, including being smoke-free, more discreet, longer high,
less intense high, and enjoying the taste. Participants in this study also endorsed many
reasons for disliking edibles, many of which were related to edibles being unpredictable
and variable in potency. Loflin and Earleywine (2014) assessed reasons why 357
participants ages 18 to 71 preferred dabs to flower methods of marijuana ingestion. They
found that participants endorsed some reasons (e.g., different kind of high, stronger
intoxication effect, effects last longer, and fewer “hits” needed) more than others (safer to
use, less side effects, and price). This finding is interesting as it found that some
preferences for dabs are associated with its potency and the stronger intoxication effect.
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This could mean that individuals who use dabs might be at a higher risk for substance use
disorders as reasons for using this method are related to a stronger intoxication effect.
Another study by Lee and colleagues (2016) assessed 2910 participant’s perceptions of
effects for those who prefer smoking or vaping marijuana. Those who smoke reported
different reasons compared to those who vape. Specifically, participants who preferred
vaping over smoking endorsed reasons of healthier, better tasting, produced better effects,
and more satisfying (Lee et al., 2016). This suggests that endorsed reasons for using a
method of ingestion may differ depending on one’s primary motive for using marijuana
(e.g., for social purposes, to experiment, coping).
Methods with more positive perceptions that are also more readily available may
influence patterns of use in the United States (Lee et al., 2016), and currently research is
extremely limited in this area. Research regarding methods of marijuana ingestion is
needed to identify emerging trends in this new legalization landscape, to inform timely
prevention and policy measures, and minimize potential dangers of certain methods of
ingestion to consumers (Daniulaityte et al., 2015; Gourdet et al., 2017; Schauer et al.,
2016).
Summary
Utilizing and elaborating on the social-cognitive/contextual developmental
models proposed by Mayes and Suchman (2006) for the developmental paths into
substance use and dependence, this cross-sectional study sought understand the influence
of contextual factors and methods of marijuana ingestion within these two models. The
current study sought to evaluate whether methods of marijuana ingestion were associated
with frequency of marijuana use over the last 30 days, problematic marijuana use, as well

51
as mental health outcomes. Furthermore, this study sought evaluate if marijuana users
endorsed distinct reasons (e.g. safety, price, different type of high) for their primary
method of ingestion. This study sought to understand if availability of methods
influenced the primary method of ingestion chosen by participants. Finally, this study
sought understand if certain methods of ingestion were associated with chronic and
escalating patterns of marijuana, both of which are associated with increased negative
short- and long-term outcomes.
Research in this area continues to be imperative as states proceed with the
legalization of marijuana for medical as well as recreational. The number of marijuana
users have steady increased over the last few years for those aged 12 and older
(Substance Abuse and Mental Health Services Administration, 2018; Substance Abuse
and Mental Health Services Administration, 2019). This increase in the percentage of the
population using marijuana, makes it imperative to have a thorough understanding of
methods of ingestion as they become increasingly diversified and accessible. The current
study becomes increasingly important to help further research on marijuana as well as
any potential negative outcomes that can arise from marijuana use as well as continued
legalization. Research of this nature can be used to create and inform prevention and
intervention programs for youth as well as young adults to mitigate the potential negative
influence of marijuana use and legalization..
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CHAPTER III
METHODS
Participants and Procedures
The current study sought to understand the effects of method of ingestion as well
as contextual factors on marijuana use and associated problems (e.g. frequency of use,
problematic use, mental health). In addition, this study sought to understand endorsed
reasons for preferring certain methods of ingestion among individuals. Participants
included community members recruited primarily through Amazon Mechanical Turk
(MTurk), as has been done in prior studies (e.g., Daniulaityte et al., 2017). MTurk is a
crowdsourcing marketplace where individuals and businesses can virtually distribute
tasks (e.g., data validation, survey participation, and content moderation) to a global
workforce. Individuals who complete the tasks are called ‘workers’ on the MTurk
platform (Amazon, 2018).
For the current study, a survey created in Qualtrics was placed in a task on MTurk
for participants to complete. Within the MTurk platform, a task was created with the title
of the dissertation and a short description: “We are currently recruiting community
members ages 18-25 to participate in a research study on marijuana use and methods of
ingestion. The goal of this study is to learn more about how you are using marijuana.”
Keywords were chosen to help participants search for the task, including marijuana,
weed, pot, dope, grass, reefer, herb, Mary Jane, concentrates, dabs, edibles, joints, blunts,
vaporizers, vaping, and smoking.
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To be eligible for the study, potential participants needed to be ages 18-25 and
report using marijuana within the last month. Individuals who self-reported meeting the
eligibility criteria clicked the Qualtrics survey link included in the task description on
MTurk. After completing informed consent online, participants completed a series of
measures through Qualtrics. At the end of the Qualtrics survey a code was provided for
the participant to manually enter in the MTurk task to show that the participant
successfully completed the task. This researcher then reviewed each task to ensure the
correct code (provided at the end of the survey) was inputted by the participant in MTurk.
Next the researcher approved the participant to be paid through MTurk. Participants were
allotted two hours to complete the survey, starting when they clicked on the link in
MTurk.
Participation was completely voluntary, anonymous, and compensated ($2.50)
based on MTurk guidelines. Data were collected from 6/10/19 – 6/20/19. Participants
included individuals from states with and without legal access to medical and/or
recreational marijuana. Both female and male participants were recruited, and
participation was not limited to certain racial or ethnic groups.
G*Power was used to calculate the necessary sample size to achieve statistical
power for this study. Cohen (1992) recommends using a power of .80 to determine
necessary sample sizes to reduce error. With this power, the sample size necessary to
achieve statistical significance in this study was 196 participants. The power calculation
was based on the most complex statistical analysis included in this study, ensuring the
sample size was sufficient for all analyses included in this study.
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Measures (see Appendix)
Demographics
Age, sex, race/ethnicity, highest level of education, annual family income and
education level, employment status, sexual orientation, relationship status, history of
family drug use, and current living situation were assessed.
Daily Sessions, Frequency, Age of Onset,
And Quantity of Cannabis Use
Inventory (DFAQ-CU)
Participants were asked to self-report on marijuana use in their lifetime and within
the past month using a modified version of the DFAQ-CU. The DFAQ-CU is a 41-item
survey that measures frequency, age of onset, and quantity of marijuana used. The
measure has a Cronbach’s alpha ranging from .69 (daily sessions) to .95 (frequency).
Internal consistency of the quantity, age of onset, and concentrate factors were .88, .81,
and .76 respectively (Cuttler & Spradlin, 2017). Evidence has been provided for the
convergent, predictive, and discriminant validity of the factors included in this measure
with similar surveys (e.g. Marijuana Smoking History Questionnaire, Cannabis Abuse
Screening Test, Cannabis Use Problems Identification Test; Cuttler & Spradlin, 2017).
Rutgers Marijuana Problem Index (RMPI)
Participants completed the RMPI (White, Labouvie, & Papadaratsakis, 2005),
which consists of 23 items and assesses negative consequences associated with marijuana
use within the last year. Items on this scale are rated from 0 to 3 (“none” to “more than 5
times”) based on the frequency of each consequence for the participant. Sample items
include “Kept smoking when you promised yourself not to” and “Neglected your
responsibilities.” The RMPI has a Cronbach’s alpha of .91 at age 18, .88 at age 21, and
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.85 at age 30 (White et al., 2005). In addition to the RMPI being validated through
research, past literature has shown negative consequences of use to be a distinct measure
of problem use as well as indicators of substance use problems (White, 1987; White &
Labouvie, 1989). Scores on all items were added for a total score.
Comprehensive Marijuana Motives
Measure (CMMM)
The CMMM (Lee et al., 2009) measured motives for using marijuana. This scale
assesses a wide-range of reasons for using marijuana. The original scale includes 12
subscales (Enjoyment, Conformity, Coping, Experimentation, Boredom, Alcohol,
Celebration, Altered Perceptions, Social Anxiety, Relative Low Risk, Sleep, and
Availability) rated on a 1 to 5 scale (“almost never/never” to “almost always/always”).
The CMMM was revised to include an additional subscale, the Social subscale from the
Marijuana Motives Measure (Simons, Correia, Carey, & Borsari, 1998), as has been done
in other past studies (Phillips et al., 2017). The CMMM has internal consistency ranging
from .78 (availability) to .89 (enjoyment, coping) across all subscales. Cronbach’s alpha
for the remaining subscales are as follows: .80 for relative low risk, .83 for altered
perceptions, .84 for alcohol, conformity, sleep, .87 for celebration, and .88 for boredom,
experimentation, social anxiety (Lee et al., 2009). The CMMM has been validated
through research comparing it with another 25-item marijuana motives questionnaire
(Simons, Correia, & Carey, 2000). Scores for all items on each subscale were totaled for
subscale scores.
General Mental Health Outcomes
The eight-item Patient Health Questionnaire Depression Scale (PHQ-8; Kroenke
& Spitzer, 2002) and the seven-item Generalized Anxiety Disorder Scale (GAD-7;
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Spitzer, Kroenke, Williams, & Löwe, 2006) were used as measures for mental health.
The PHQ-8 asks participants to rate the number of days in the past two weeks they
experienced a particular depressive symptom. The PHQ-8 has an internal consistency of
.86, with a score of >10 having an 88% sensitivity and 88% specificity for major
depression (Kroenke & Spitzer, 2002). The GAD-7 asks participants to rate the number
of days in the past two weeks they experienced a particular symptom of anxiety. The
GAD-7 has an internal consistency of .92 (Spitzer et al., 2006), with a score of having an
89% sensitivity and 82% specificity. For both questionnaires the response options range
from 0 to 3 (“not at all” to “nearly every day”). Scores on all items for both measures
were added for a total score.
Patterns and Transitions in Marijuana
Use
Developed for use in this study, past marijuana use patterns were assessed by a
series of questions focusing on frequency, quantity, and dose (if known) of marijuana use
during the past five years. This was assessed by creating a table where participants were
able to indicate the frequency and quantity of marijuana used during the years following
age of onset, as well as when they started using at their current level of use. Additionally,
participants were asked if they changed methods during the years following onset. If
participants changed methods, they were asked to write in the reason for changing their
method of marijuana ingestion.
Contextual Factors
To assess availability of different methods of marijuana ingestion questions were
developed for this study including: what is your current state of residence, how easy is it
for you to obtain the following forms of marijuana where you currently live, and how
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easy is it for you to obtain these materials or devices to use marijuana where you
currently live. Two of these questions involved a rating of ease of obtaining specific
methods of ingestion (“very easy,” “moderately easy,” “neither easy nor difficult,”
moderately difficult,” and “very difficult”). The remaining questions asked the source
where the participant purchased/obtained marijuana (e.g. friend, dispensary, dealer, etc.),
as well as the current U.S. state of residence of the participant.
Reasons for Primary Method of
Marijuana Ingestion
The Reasons for Primary Method of Marijuana Ingestion comprises multiple
questions that assess the top reason users endorse for their primary method of ingestion,
as well as additional reasons. These questions were developed for this study based on
previous research that has measured reasons related to specific methods of ingestion
(Giombi et al., 2018; Lee et al., 2016; Loflin & Earleywine, 2014). Participants were
asked to endorse reasons for their primary method of ingestion as well as methods they
use more than 25% of the time.
Statistical Procedures
Data were analyzed using SPSS statistical software. A total of 350 participants
completed the online consent. Participants who did not consent (n = 2) nor complete the
survey (n = 49), displayed unusual response patterns (i.e. answering every question the
same; n = 25), or self-reported being older than the study criteria when asked to input
age, were excluded from the analyses (n = 15).
A total of 261 participants were included in the ensuing statistical analyses.
Because participants were required to answer every question (i.e., no option was given to
skip items), there were no missing data. Analyses (i.e. independent t-tests and chi-square)
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were conducted to assess whether those who were excluded from the final sample (e.g.
did not complete the questionnaire) differed on key variables from those who were
included. There was a significant difference in mean age between included (23.60) and
excluded (24.38) participants (t121.519 = -3.264, p = .05), which can be explained by the 15
participants who indicated they were within the eligibility age requirements but went on
to report ages outside of the eligibility requirements when asked to manually input age.
Included and excluded participants differed significantly with ethnicity X2 (5, N = 350) =
41.888, p = .000), with the excluded participants being less than expected numbers for
ethnicities of Caucasian, African American, and Asian. There was no significant
difference between included and excluded participants regarding gender (X2 (2, N = 350)
= 3.680, p = .159). There was a significant difference in highest level of education
between included and excluded participants, with excluded participants having lower
levels of education (i.e. less than 12th grade, GED, high school diploma, and some
college) than expected compared with the included participants (X 2 (6, N = 350) =
32.934, p = .000). Frequency of marijuana use over the last 30 days was not significantly
different between participants included (13.45) and excluded (13.60) from the analyses
(t126.320 = .905, p = .776).
Responses to questions on marijuana use frequency, age of onset, and total years
of use that were deemed outliers were Winsorized (Fuller, 1991) to the highest or lowest
reasonable value, determined by the natural cutoffs in the sample and researcher
judgment of a realistic maximum value. Responses for marijuana frequency over the last
30 days that were higher than 30 days were decreased to 30. Four participants reported
using marijuana before the age of 9 (i.e., ages 4 and 5). These responses were increased
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to 9 as it was a natural cut off in the sample. Finally, years of total use were corrected by
subtracting current age from age of first use for participants who reported total years of
use larger than what would be expected given the ages they self-reported. Descriptive
statistics were reported for the entire sample. Mean days of marijuana use in the past 30
days, age of onset, and lifetime use were calculated. Frequencies for primary method of
ingestion were calculated for the entire sample. See Table 4 for a summary of the
variables that were derived from each measure included in this study. For all
demographic variables and marijuana use statistics, all 261 participants were included. A
low incidence of dab users (n =4) were found in the sample and when examining their
marijuana use frequency, they were deemed as outliers and excluded from the remaining
analyses, except for the descriptive analyses in RQ4 and RQ6.
Table 4
Variables derived from each measure included in the current study
Measure
Variables
DFAQ-CU
RMPI

Frequency of use, primary method of ingestion,
secondary methods of ingestion, source of marijuana
Problematic use

CMMM

Motives for using marijuana

PHQ-8

Depression

GAD-7

Anxiety

Patterns and
Transitions

Trajectory classes, frequency and quantity of use over
last 5 years, method of ingestion used for last 5 years,
transitions in method of ingestion over last 5 years,
reasons for transition in method of ingestion
State of residence, perceived ease of access

Contextual Factors

Reasons for
Endorsed reasons for using a certain method of
Primary Method of ingestion
Ingestion
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Q1

Are certain methods of marijuana ingestion related to higher frequency of
use and problematic use?

The analysis for Research Question One focused on the relationship between
method of marijuana ingestion, frequency of use over the last 30 days, and problematic
use. Dependent variables were the number of days used over the last 30 days and
problematic use. Problematic use was calculated using the total sums from the RMPI.
The independent variable for this question was method of marijuana ingestion, which
included three levels: smoking, vaping, and oral. A one-way MANCOVA statistical
analysis was used to understand these relationships. Covariates for this analysis were
gender, age, race, and level of education. The first four assumptions for this MANCOVA
analysis were met as there are two continuous dependent variables, a categorical
independent variable, at least one continuous covariate, and independent observations.
Additionally, there was a linear relationship between the dependent variables of number
of days used over the last 30 days and problematic use as assessed by visual inspection of
a scatterplot utilizing a loess line fit percentage of 90%.
Q2

Are certain methods of ingestion related to specific motives for use?

The analysis for Research Question Two focused on the relationship between
method of ingestion and motives for marijuana use. The dependent variable was
marijuana motives scales of enjoyment, conformity, coping, experimentation, altered
perceptions, and availability, with the independent variable being methods of marijuana
ingestion, which included three levels. A one-way MANCOVA statistical analysis was
used to understand this relationship. Covariates for this analysis were gender, age, race,
level of education, frequency of marijuana use over the last 30 days, and problematic use.
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The first four assumptions for this MANCOVA analysis were met as there are two
continuous dependent variables, a categorical independent variable, at least one
continuous covariate, and independent observations. Additionally, there was a linear
relationship between the dependent variables of motives scales for marijuana use of
enjoyment, conformity, coping, experimentation, altered perceptions, and availability as
assessed by visual inspection of a scatterplot utilizing a loess line fit percentage of 90%.
Q3

Are certain methods of ingestion associated with negative mental health
outcomes?

The analysis for Research Question Three focused on the relationship between
method of ingestion and mental health outcomes. Dependent variables were mental health
outcomes (i.e., depression [PHQ-8] and anxiety [GAD-7]). The independent variable was
methods of marijuana ingestion, which included three levels. A one-way MANCOVA
statistical analysis was used to understand these relationships. Covariates for this analysis
were gender, age, race, level of education, frequency of marijuana use over the last 30
days, and problematic use. The first four assumptions for this MANCOVA analysis were
met as there are two continuous dependent variables, a categorical independent variable,
at least one continuous covariate, and independent observations. Additionally, there was a
linear relationship between the dependent variables of depression (PHQ-8) and anxiety
(GAD-7) as assessed by visual inspection of a scatterplot utilizing a loess line fit
percentage of 90%.
Q4

Are certain methods of ingestion related to historical and current patterns
of use in terms of frequency and transitions in methods over the last five
years to current use?

The Research Question Four analysis consisted of multiple steps. First, individual
changes in frequency of use over time were measured using linear mixed models and a
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linear growth curve model (Shek & Ma, 2011). This determined individual growth curves
(IGC) of use over time based on frequency of marijuana use. This growth measurement
variable was then used in a two-step cluster analysis, due to the size of the data set, to
determine clusters or classes of individuals with similar growth (e.g. escalating,
decreasing). A Fisher’s Exact test statistical analysis was then used to analyze the
relationship between trajectory/class membership and current method of marijuana
ingestion. Assumptions for this Fisher’s Exact test were met as this analysis comprised of
two variables measured at the categorical level with independent observations and
collected using cross-sectional sampling. Regarding transitions between methods,
descriptive/visual analysis is reported to understand the relationship between endorsed
transition reason and method of marijuana ingestion across the five years measured.
Additionally, similar analyses used to derive the trajectory groups were used to create
classes for transitions in method of ingestion (e.g., no change in method, switching of
method). A Chi-square statistical analysis was used to analyze the relationship between
trajectory class and transition of method of ingestion class. Assumptions for this Chisquare test of independence were met as this analysis comprised of two variables that
were measured at the categorical level with independence of observations. Data were
collected using cross-sectional sampling and more than 80% of the cells had counts
greater than or equal to five.
Q5

Are primary methods of ingestion influenced by availability or awareness
of methods?

The analysis for Research Question Five was composed of multiple steps. First,
participants were grouped by states into three categories: 1) legal marijuana for
recreational and medical purposes (n = 11 states, n = 72 participants), 2) legal marijuana
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for medical purposes (n = 35 states, n = 155 participants), 3) illegal marijuana for any
purpose (n = 4 states, n = 30 participants). This variable was used in a Chi-Square
analysis along with method of ingestion to assess their relationship. Assumptions for this
Chi-square test of independence were met as this analysis comprised of two variables that
were measured at the categorical level with independence of observations. Data were
collected using cross-sectional sampling and more than 80% of the cells had counts
greater than or equal to five. A Fisher’s Exact test analysis was completed with the source
of marijuana (e.g. friend, dispensary, dealer) and legal status groupings. Assumptions for
this Fisher’s Exact test were met as this analysis comprised of two variables measured at
the categorical level with independent observations and data collected using crosssectional sampling. Finally, a series of ordinal logistical regressions were used to
determine the ease of accessibility for method of ingestion by state legality grouping. In
this analysis the independent variable was state legality grouping, which included three
levels, with the dependent variable being the perceived ease of access for each method of
ingestion. Covariates for this analysis were age, gender, race, and level of education.
Assumptions for this series of ordinal logistical regressions were met as the dependent
variables were ordinal, the independent variable is categorical, there was no
multicollinearity due to just having one independent variable, and the assumption of
proportional odds was met for each analysis as assessed by a full likelihood ratio test.
Q6

Are endorsed reasons (e.g. safety, type of high, price) for using certain
methods different across methods of marijuana ingestion?

Finally, the analyses for Research Question Six consisted of a Chi-Square analysis
and descriptive/visual analysis. This Chi-square analysis comprised of two variables that
were measured at the categorical level with independence of observations and data that

64
were collected using cross-sectional sampling, meaning three assumptions for the Chisquare analysis were met. This Chi-square analysis did not meet the assumption of more
than 80% of the cells had counts greater than or equal to five. Therefore, a Chi-Square
analysis utilizing the Monte Carlo sampling method (Mehta & Patel, 2011), due to sparse
(many cells with less than five) and unbalanced data, was used with primary method of
ingestion and endorsed reasons as the variables. Next, descriptive statistics were reported
with methods of ingestion used 25% of the time or more and endorsed reasons as the
variables. The following figure outlines the research questions proposed in the current
study and their relationship with method of ingestion.

Contextual factors (RQ5)

Method of ingestion

Frequency of use
and problematic use
(RQ1)

Reasons for use
(RQ6)

Marijuana use
trajectories and
transitions (RQ4)

Marijuana use
motives (RQ2)

Mental health (RQ3)

Figure 5. Visualization of research questions proposed in the current study and their
relationship.
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CHAPTER IV
RESULTS
Demographics and Marijuana Use Statistics
Demographic variables of participants included (n = 261) from the analysis are
displayed in Table 5. On average participants took 25 minutes to complete the survey.
Participants were from the United States, per eligibility requirements. Participants were
located in 39 states and Washington D.C. States with the highest percent of participants
were: California (n = 36, 14%), Florida (n = 20, 7.8%), Indiana (n = 24, 9.3%), New
York (n = 14, 5.4%), and Texas (n = 41, 16%). According to current census data, the
percentage of females in this study (73.3%) is higher than U.S. census data of 50.8%.
Annual household income is lower than the recorded income from the U.S. census data
($60,293). Finally, ethnicity in this sample is different from the ethnic background of
persons completing the U.S. census, with fewer White (U.S. census = 76.5%), fewer
Black (U.S. census = 13.4%), more American Indian/Alaska Native (U.S. census =
1.3%), more Asian (U.S. census = 5.9%), fewer Hispanic/Latino (U.S. census = 18.3%),
and more Biracial/Multiracial (U.S. census = 2.7%) participants (United States, 2020).
Compared to previous studies on marijuana users (i.e., Loflin & Earleywine, 2014;
Phillips et al., 2017) this sample differed regarding percentages of females, but not
regarding ethnicities, except for studies looking at developmental trajectories where
differences in gender and ethnicity were present (i.e., Brook et al., 2016; Flory et al.,
2004). Per eligibility requirements, all participants reported marijuana use in the last 30
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days, with a mean of 13.47 (SD = 9.67) days used in the last 30 (Range = 1-30).
Additional marijuana use statistics are included in Table 6.
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Table 5
Demographic and background characteristics (n =261)
Measure/variable
Age

n (%)

Gender
Female
Male
Prefer not to respond

192 (73.3)
66 (25.2)
3 (1.1)

Sexual Orientation
Gay Male
Lesbian
Bisexual
Heterosexual
Asexual
Prefer not to respond

6 (2.3)
4 (1.5)
62 (23.8)
186 (71.3)
1 (.4)
2 (.8)

Relationship Status
Single
Married/Civil Union/Living
Together Long-Term
Seriously Dating/Exclusive
Relationship
Separated/Divorced

Median

168 (64.1)
51 (19.5)
39 (14.9)
3 (1.1)

Annual Household Income
Current Living Situation
Living Alone
Living with Others
Living in University
Housing
Living in Residential
Facility
Staying with Relative or
Friend
Staying in a Shelter or
Homeless
Race/Ethnicity
Caucasian
Hispanic/Latino
Black
Native American / Alaskan
Native
Asian

Mean (Range)
23.6 (18-25)

$30,000 - 40,000

115 (44.1)
115 (44.1)
15 (5.7)
7 (2.7)
8 (3.1)
1 (.4)

143 (54.8)
13 (5)
22 (8.4)
15 (17)
45 (17.2)
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Table 5, continued
Measure/variable
Biracial/Multiracial
Highest Level of Education
GED
High School Diploma
Some College
Bachelor’s Degree
Advanced Graduate
Degree
Don’t Know
Employment Status
Employed Full Time
Employed Part Time
Unemployed
In School Part Time
In School Full Time
Working Part Time,
School Full Time
Working Full Time,
School Full Time
Working Part Time
and Full Time
Working Part
Time/Full Time, in
School Part Time
Familial Drug Use
No One
Father
Mother
Brother
Sister
Other

n (%)

Mean (Range)

Median

23 (8.8)

1 (.4)
26 (10)
60 (23)
146 (55.9)
27 (10.3)
1 (.4)

191 (72.9)
38 (14.5)
12 (4.6)
3 (1.1)
9 (3.4)
2 (.8)
2 (.8)
3 (1.1)
1 (.4)

115
108
32
42
18
5

Most participants described smoking (using a joint, blunt, hand pipe, hookah, or
bong) as their primary method of ingestion (n = 187, 71.6%). For 24 participants this was
their only method of ingestion, however, 238 participants reported using additional
methods of marijuana ingestion more than 25% of the time including smoking (n = 291;
using a joint, blunt, hand pipe, hookah or bong). Participants selected every method used
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25% of the time or more. Additional method of ingestion statistics are included in Table
6. It is important to note that the majority of participants who reported using additional
methods of marijuana ingestion 25% of the time reported using multiple methods.
One hundred and ninety-seven (75.2%) of the participants reported their primary
form used as marijuana (e.g. flower, bud, herb). Edibles were reported as the primary
form of marijuana for 45 (17.2%) participants, with concentrates being used by 19
(7.3%). Two hundred-thirteen participants also reported using other methods over 25% of
the time, see Table 6. A small number of participants reported ever having a medical
marijuana registry card (n = 57), with many (36 out of 57) reporting using marijuana
recreationally and medically. The majority of participants purchased their marijuana from
a friend (n = 87, 33.3%), followed by a dealer (n = 73, 28%), retail store (n = 55, 21.1%),
medical dispensary (n = 26, 10%), given for free (n = 17, 6.5%), or grown by the
participant (n = 3, 1.1%). Additional marijuana use statistics are included in Table 6. See
Table 7 for statistics regarding participants included in independent variables excluding
participants who endorsed using dabs as their primary method of ingestion (n = 4).
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Table 6
Marijuana use statistics (n =261)
Measure/variable
Frequency
Multiple times per day
Once per day
5-6 times per week
3-4 times per week
2 times per week
2-3 times per month
1-2 times per month

n (%)

Mean (Range)

30 (11.5)
17 (6.5)
15 (5.7)
28 (10.7)
37 (14.2)
42 (16.1)
67 (24.7)

Age of onset

17.66 (9-25)

Total years of use

5.23 (1-15)

Age of monthly use

19.07 (9-25)

Age of daily use

19.29 (9-25)

Primary method of ingestion
Smoking
Joint
Blunts
Hand pipe
Bong
Hookah
Vaping
Vaporizer
E-cigarette device
Oral*
Edibles*
Dabbing
Dab rig
Secondary methods of ingestion
Smoking
Joints
Blunts
Hand pipe
Bong
Hookah
Vaping
Vaporizer
E-cigarette device

66 (25.3)
17 (6.5)
51 (19.5)
35 (13.4)
18 (6.9)
28 (10.7)
24 (9.2)
18 (6.9)*
4 (1.5)

94 (39.5)
50 (21)
68 (28.6)
41 (17.2)
38 (16)
30 (12.6)
30 (12.6)
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Table 6, continued
Measure/variable
Oral
Edibles
Dabbing
Dab rig
Topical
Topicals
Other
CBD oil

n (%)

Mean (Range)

41 (17.2)
9 (3.8)
3 (1.3)
1 (.4)

Primary form of marijuana used
Marijuana
Edibles
Concentrates

197 (75.2)
45 (17.2)
19 (7.3)

Secondary forms used
Marijuana
Edibles*
Concentrates

135 (63.4)
72 (33.8)*
50 (23.5)

Note. * More participants endorsed using an oral form of marijuana than an oral method
of ingestion
Table 7
Statistics for participants included in independent variables for subsequent analyses,
excluding dabbers (n =257)
Measure/variable
n (%)
Grouping by method of ingestion
Smoking
Vaping
Oral

187 (72.7)
52 (20.2)
18 (7)

Trajectory class
Heavy
Escalating
Moderate
Low

17 (6.6)
97 (37.7)
101 (39.3)
42 (16.3)

Transition in methods
No to low transition
Multiple transitions

186 (72.4)
71 (27.6)

Groupings by state legality
Illegal
Recreational and medicinal laws
Medicinal laws only

30 (11.7)
72 (28)
155 (60.3)
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Analysis One: Problematic Use and Frequency of Use
A one-way MANCOVA analysis sought to answer the question of whether certain
methods of marijuana ingestion, due to immediate effects and potential higher potency,
are related to increase in frequency of use and problematic use. Dependent variables for
this analysis were the number of days used over the last 30 days and problematic use
(calculated from the RMPI). The independent variable for this analysis was method of
marijuana ingestion (3 levels =smoking, vaping, and oral), with covariates of gender, age,
race, and level of education. There was no statistically significant difference between
methods of ingestion groups on the combined dependent variables after controlling for
gender, age, race, and level of education, F(4, 496) = 1.077, p = .367, Wilks' Λ = .983.
Because this analysis was not significant, no follow up analyses were conducted.
Analysis Two: Marijuana Use Motives
A one-way MANCOVA analysis was used to answer the question of certain
methods of ingestion being related to specific motives (e.g. coping) for use due to higher
potency and immediate effects. The dependent variable for this analysis was certain
marijuana motives, derived from the subscales of the CMMM, with the independent
variable being methods of marijuana ingestion (3 levels = smoking, vaping, and oral).
Subscales included in this analysis were enjoyment, conformity, coping, experimentation,
altered perceptions, and availability. There was no statistically significant difference
between methods of ingestion groups on the combined dependent variables after
controlling for gender, age, race, level of education, frequency of marijuana use over the
last 30 days, and problematic use, F(12, 484) = .879, p = .521, Wilks' Λ = .958. Because
this analysis was not significant, no follow up analyses were conducted.
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Analysis Three: Mental Health
This one-way MANCOVA analysis sought to answer the question if certain
methods of marijuana ingestion are associated with negative mental health outcomes,
derived from the GAD-7 and PHQ-8. Dependent variables for this analysis were mental
health outcomes (i.e., PHQ-8 or depression and GAD-7 or anxiety). The independent
variable was methods of ingestion (3 levels = smoking, vaping, and oral), with covariates
of gender, age, race, level of education, frequency of marijuana use over the last 30 days,
and problematic use. There was no statistically significant difference between methods of
ingestion groups on the combined dependent variables after controlling for gender, age,
race, level of education, frequency of marijuana use over the last 30 days, and
problematic use F(4, 492) = .759, p = .245, Wilks' Λ = .988. Since this analysis was not
significant, no follow up analyses were conducted.
Analysis Four: Marijuana Use Trajectories and Transitions
Analyses for this research question sought to understand patterns of use over the
last five years in terms of frequency of use, in addition to transitions in method of
ingestion to see if heavy/chronic and escalating marijuana use patterns are related to
methods in ingestion with immediate effects and potential higher potency. For this
analysis, the frequency of use variable was recoded to collapse similar frequency use
groups (i.e., 0 = no use, 1 = few times per year, 2 = few times per month, 3 = 1-4 times
per week, 4 = 5 times per week to more than once per day). First, individual changes in
use over time in frequency of use, in addition to transitions in method of ingestion were
measured by using a linear growth curve model to determine individual growth curves
over time. These growth variables were then used in two-step cluster analyses to
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determine classes of individuals with similar growth patterns over time. Three cluster
analyses were performed to ensure the classes were the best fit for the data regarding
frequency of use. In the first two-step cluster analysis, clusters were determined
automatically, which led to a cluster quality falling within the good range, and a ratio of
sizes of 2.58. The subsequent two-step cluster analyses were conducted with specified
numbers of clusters of three and five, which resulted in cluster qualities falling within the
poor ranges. As the cluster analysis with four groups led to the best quality, four use
trajectories were chosen. Similarly, the same two-step cluster analysis process was used
to determine clusters for transitions in method of ingestion, which resulted in two classes
automatically determined. The cluster quality for this analysis fell within the good range,
with a ratio of sizes of 2.54. Additional analyses with specified clusters of one and three
resulted in cluster qualities falling within the poor range. For both final cluster analyses
(i.e. frequency of use and transitions) these groups were assigned numerical values that
were used to examine the growth variables across the separate groups throughout the five
years measured. Visual analysis via a scatterplot was used to understand how the groups
differed across the five years measured (e.g. increasing frequency use, maintaining).
Through this, the nature of the groups was discovered (e.g. escalators, heavy users, no
transition). See Table 8 for frequencies of participants in trajectory classes.
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Table 8
Classes for use trajectory and transition in methods
Measure/variable
n (%)
Trajectory Class
Heavy
Escalating
Moderate
Low
Transition in Methods
No to Low Transition
Multiple Transitions

46 (17.9)
103 (40.1)
68 (26.5)
40 (15.6)
186 (72.4)
71 (27.6)

After these classes were established, a Fisher’s Exact test analysis was conducted
to further understand the relationship between method of ingestion and trajectory class. A
Chi-square test of independence analysis was conducted to understand the relationship
between transition in methods and trajectory class. Descriptive analyses are reported for
endorsed transition reason and method of ingestion.
A Fisher’s Exact test analysis was completed to examine the relationship between
method of ingestion and trajectory class. The relationship between method of ingestion
and trajectory class was not significant X2 (6, N = 257) = 6.597, p = .352, see Table 9 for
results.
Table 9
Results for Fisher’s Exact test analysis for analysis four
Current Method
Trajectory Class
of Ingestion
Low
Moderate
Escalating
Smoking
27
55
72
Vaping
9
9
26
Oral
4
4
5
Total
40
68
103

Heavy
33
8
5
46

Total
187
52
18
257

A Chi-square test of independence was performed to examine the relationship
between trajectory class and transition in method of ingestion. The relationship between
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these variables was not significant X2 (3, N = 257) = 1.905, p = .592, see Table 10 for
results.
Table 10
Results for Chi-square analysis for analysis four
Transition in Method
Trajectory Class
of Ingestion
Low Moderate
Escalating
Heavy
No to Low Transition
29
46
79
32
Multiple Transitions
11
22
24
14
Total
40
68
103
46

Total
186
71
257

Due to low frequencies, transition in method of ingestion across the five years
measured are reported descriptively to see if there were specific reasons depending on the
method of ingestion for transitioning. In this analysis, participants responded to each
transition in method of ingestion they had over the course of the five years measured,
with many participants having multiple transitions. Regarding smoking, higher
frequencies of participants reported “fewer “hits” are necessary” (n =28), “safer to use”
(n =26), “effects last longer” (n =22), and “different kind of high” (n =21) as their reason
for transitioning to a smoking method of ingestion, see Figure 6 for additional reasons.
For vaping, higher frequencies of participants reported “friends use/recommended the
method” (n =14) and “fewer “hits” are necessary” (n =9) as their reason for transitioning
to a vaping method of ingestion, see Figure 7 for additional reasons. Regarding dabbing,
higher frequencies of participants reported “friends use/recommended the method” (n =4)
and “fewer “hits” are necessary” (n =4) as their reason for transitioning to a dabbing
method of ingestion. For oral methods of ingestion, higher frequencies of participants
reported “effects last longer” (n =3), “safer to use” (n =3), and “less side effects” (n =3)
as their reason for transitioning. Regarding topicals, reasons for transitions of “effects last
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longer” (n =1) and “friends use/recommended this method” were reported (n =1). For
additional descriptive results, see Table 11.
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Figure 6. Descriptive results for smoking method of ingestion and reason for transitioning
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Figure 7. Descriptive results for vaping method of ingestion and reason for transitioning
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Table 11
Descriptive results for method of ingestion and reason for transitioning
Reason for Use
Method of Ingestion
Smoking

Vaping

Dabbing

Oral

Topical

Different kind of high

21

5

0

1

0

Stronger intoxication effect

19

1

0

0

0

Effects last longer

22

6

3

3

1

Fewer “hits” are necessary

28

9

4

1

0

Safer to use

26

3

3

3

0

Less side effects

11

5

2

3

0

Friends use/recommended this
method
Family members
use/recommended this method
Tastes better

14

14

4

1

1

6

6

3

0

0

8

3

2

0

0

Is easily accessible

9

4

3

1

0

Is less expensive

4

0

1

1

0

Is more discreet

3

0

0

0

0

As a part of the descriptive analysis, types of transitions between methods were
recorded. Out of the 101 participants who reported any transition in method over the past
five years, the majority (n = 20) transitioned only within smoking methods of ingestion.
A number of participants reported alternating between vaping and smoking over the five
years measured (n = 10). A total of eight participants transitioned from vaping to
smoking. Seven participants transitioned from both smoking to oral (n = 7) and smoking
to vaping methods of ingestion (n = 7). Overall, 50 participants transitioned to a different
method of ingestion at the end of the five years measured. In contrast, 43 participants
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ultimately transitioned (started with one method, transitioned to different methods, then
returned to the original method) to the same method of ingestion they first reported. For
additional descriptive results, see Table 12.
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Table 12
Descriptive results for types of transitions (n = 101)
Type of Transitions
Overall Different Method of Ingestion
Alternating vaping and dabbing
Alternating vaping and smoking
Dabbing to smoking
Dabbing, oral, vaping, smoking, vaping
Dabbing, smoking, vaping
Dabbing, smoking, vaping, dabbing, smoking
Dabbing, vaping, oral, smoking
Dabbing, vaping, smoking
Oral, dabbing, vaping, smoking, vaping
Oral, smoking, vaping
Smoking to oral
Smoking to vaping
Smoking, dabbing, smoking, vaping
Smoking, oral, vaping
Smoking, vaping, oral, vaping
Topical, vaping, smoking
Vaping to dabbing
Vaping to oral
Vaping to smoking
Vaping, smoking, dabbing, smoking
Vaping, topical, vaping, oral
Overall Same Method of Ingestion
Smoking to different smoking methods
Smoking, dabbing, smoking
Smoking, dabbing, vaping, smoking
Smoking, oral, dabbing, smoking
Smoking, oral, smoking
Smoking, vaping, dabbing, smoking
Smoking, vaping, smoking
Smoking, vaping, smoking, topical, smoking
Vaping, dabbing, smoking, vaping
Vaping, dabbing, vaping
Vaping, oral, vaping
Vaping to different vaping method
Vaping, smoking, dabbing, vaping
Vaping, smoking, vaping

n
3
10
1
1
1
1
1
3
1
3
7
7
1
2
1
1
3
1
8
1
1

20
4
2
1
1
2
3
1
1
2
1
3
1
1
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Analysis Five: Contextual Factors
These analyses sought to answer the question if primary methods of ingestion are
influenced by availability or perceived ease of access for certain methods of ingestion,
with the notion that certain methods of ingestion may be more accessible for individuals,
leading to these methods by default being primary methods of ingestion. This question
was answered with multiple analyses including a Chi-square test of independence,
Fisher’s Exact test, and a series of ordinal logistical regression analyses. Frequencies of
participants by state legality grouping are included in Table 13.
Table 13
Grouping by state legality
Measure/variable
Illegal
Recreational Laws
Medical Laws

n (%)
30 (11.7)
72 (28)
155 (60.3)

A Chi-square test of independence was performed to examine the relationship
between method of ingestion and state legality. The relationship between these variables
was not significant X2 (4, N = 257) = 7.220, p = .125, see Table 14 for results. To
examine the relationship between source of marijuana and state legality a Fisher’s Exact
test was performed. The relationship between these variables was significant X2 (10, N =
257) = 45.602, p < .001, and the association was moderately strong (Cohen, 1988)
(Cramer’s V = .298). For participants in states where marijuana is recreationally legal,
more participants purchased marijuana from retail stores/dispensaries than expected if
legal status was independent of source of marijuana, with an adjusted standardized
residual of 6.3. Additionally, in recreationally legal states fewer participants than
expected purchased marijuana from a dealer or friend if legal status of marijuana was
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independent of source of marijuana, with adjusted standardized residuals of -3.0 and -2.5,
respectively. In states where marijuana was medicinally legal, fewer participants
purchased marijuana from retail stores/dispensaries than expected if legal status was
independent of source of marijuana, with an adjusted standardized residual of -4.8. More
participants than expected in states where marijuana was medicinally legal purchased
from a dealer if legal status was independent of source, with an adjusted standardized
residual of 2.9 (Agresti, 2013). Of note, three participants purchased from a medical
dispensary by crossing state lines. The participants who purchased from a medical
dispensary were located in states bordering those with medicinal marijuana laws, see
Table 15 for results.
Table 14
Results for first Chi-square analysis for analysis five
Current Method of
Legal Status
Ingestion
Recreationally
Medicinally
Legal
Legal
Smoking
49
116
Vaping
14
31
Oral
10
7
Total
73
154

Illegal

Total

22
7
1
30

187
52
18
257
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Table 15
Results for Fisher’s Exact test analysis for analysis five
Source of Marijuana
Legal Status
Recreationally Medicinally
Legal
Legal
Purchase from retail
34
17
store/dispensary for those over age
(6.3)
(-4.8)
21 (you PERSONALLY buy it
from a retail store/dispensary)
Purchase from medical dispensary
(you PERSONALLY have a
medical marijuana card)

Illegal

Total

3
(-1.6)

54

8
(.4)

14
(-.4)

3
(.1)

25

Purchase from a dealer

11
(-3.0)

54
(2.9)

8
(-.2)

73

Purchase from a friend

16
(-2.5)

57
(1.5)

13
(1.2)

86

It’s given to me for free
(friend/family)

3
(-.9)

10
(.7)

2
(.1)

15

1
2
1
(1.2)
(-.9)
(.2)
Total
73
154
30
Note. Adjusted residuals appear in parentheses below observed frequencies.

4

I grow my own

257

A series of ordinal logistical regression analyses sought to understand if certain
methods of ingestion are associated with differing perceived ease of access based on the
legal status of marijuana. The dependent variable for this set of analyses was perceived
ease of access that differed by method of ingestion (i.e., joints, blunts, hand pipes, bongs
[water pipe], hookahs, vaporizers, e-cigarette devices, dab rigs, edibles, and topicals). All
analyses had an independent variable of state legality grouping (i.e., recreationally legal,
medicinally legal, illegal) with covariates of gender, age, race, and level of education. For
joints, blunts, hand pipes, hookah, and e-cigarette devices state legality grouping did not
have a statistically significant effect on the prediction of perceived ease of access, see

86
Table 16 for statistical results. Regarding bongs, state legality grouping did have a
statistically significant effect, with a higher level of education (i.e., GED to advanced
graduate degree) leading to a 1.409 increase in perceived difficulty. For vaporizers, there
was a significant effect, with a higher level of education leading to an increase in
perceived difficulty of 1.509. Finally, regarding dab rigs, edibles, and topicals, state
legality grouping did have a statistically significant effect with ethnicity significantly
contributing to the model. Specifically, being not Caucasian was associated with
increased perceived difficulties of 1.214, 1.138, and 1.156 for dab rigs, edibles, and
topicals, respectively. For additional statistical results see Table 16.
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Table 16
Statistical results for ordinal regression analyses
Method of
ingestion
Joints

df

Wald

p

2

2.428

.297

Blunts

2

1.635

.442

Hand pipes

2

2.769

.250

Bongs

2
1
1
1

9.597
5.763
8.148
5.572

.008*
.016*
.004**
.018*

Hookah

2

5.524

.063

Vaporizers

2
1
1
1
1

9.160
7.873
5.323
8.068
22.830

.010*
.005**
.021*
.005**
.001***

2

4.619

.099

2
1
1
1

13.189
4.297
12.966
14.646

2
1
1
1
2
1
1
1

E-cigarette
devices
Dab rigs

Edibles

Topicals

Odds
Ratio

CI (95%)

IV/Covariate

2.597
2.129
1.409

1.191 - 5.661
1.267 - 3.576
1.060 - 1.874

Illegal
Medicinally legal
Level of education

3.037
1.827
1.509
1.278

1.398 - 6.598
1.095 - 3.049
1.136 - 2.005
1.156 - 1.414

Illegal
Medicinally legal
Level of Education
Ethnicity

.001***
.038*
.001***
.001***

2.254
2.561
1.214

1.045 - 4.861
1.535 - 4.272
1.099 - 1.321

Illegal
Medicinally legal
Ethnicity

20.488
9.283
19.226
6.685

.001***
.002**
.001***
.010*

3.334
3.191
1.138

1.536 - 7.233
1.900 - 5.361
1.031 - 1.255

Illegal
Medicinally legal
Ethnicity

17.832
7.672
16.911
8.449

.001***
.006**
.001***
.004**

2.972
2.943
1.156

1.375 - 6.422
1.759 - 4.922
1.048 - 1.275

Illegal
Medicinally legal
Ethnicity

Note. *p <.05; ** p < 01; *** p <.001
Analysis Six: Reasons for Use
A Chi-square test of independence, utilizing Monte Carlo sampling due to sparse
(multiple cells with zero or less than five cell counts) and unbalanced data, was
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performed to examine the relationship between method of ingestion and reason for use,
with the assumption that users endorse distinct reasons for each method of ingestion. The
relationship between these variables was significant X2 (24, N = 257) = 63.258, p < .001,
based on 10,000 random samples from this data set, using a starting seed of 624,387,341,
see Table 17 for results. The association was moderately strong Cramer’s V = .351
(Cohen, 1988). Regarding smoking, more participants reported is “easily accessible” as
their reason for use than expected if reason for use was independent of method of
ingestion, with an adjusted standardized residual of 3.2. Fewer participants reported
“recommended by family members” and “is more discrete” as smoking reasons for use
than expected if reason for use was independent of method of ingestion, with adjusted
standardized residuals of -3.1 and -4.5 respectively. More participants reported “safer to
use”, “recommended by family members”, and “is more discreet” as vaping reasons for
use than expected, if method of ingestion was independent of reasons for use, with
adjusted standardized residuals of 1.9, 3.9, and 3.4, respectively. For vaping, fewer
participants than expected reported “effects last longer” and “is easily accessible” as
reasons for use if reasons for use was independent of method of ingestion, with adjusted
standardized residuals of -1.7 and -2.4 respectively. Regarding oral, more participants
reported “effects last longer” and “is more discreet” than expected, if reason for use was
independent of method of ingestion, with adjusted standardized residuals of 1.8 and 2.5
respectively. Fewer participants than expected reported “is easily accessible” for oral
methods of ingestion if reasons for use was independent of method of ingestion, with an
adjusted standardized residual of -1.8, see Table 17 for additional results.
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Table 17
Results for Chi-square analysis for analysis six
Reason for Use
Method of Ingestion
Smoking
Vaping
Oral
Different kind of high
15
2
2
(.6)
(-1.1)
(.6)

Total
19

Stronger intoxication effect

17
(.9)

4
(-.1)

0
(-1.3)

21

Effects last longer

34
(.5)

5
(-1.7)

6
(1.8)

45

Fewer “hits” are necessary

31
(.7)

8
(.0)

1
(-1.2)

40

Safer to use

16
(-1.4)

9
(1.9)

1
(-.7)

26

Less side effects

5
(-1.2)

3
(1.0)

1
(.5)

9

Friends use/recommended this
method

17
(.1)

5
(.2)

1
(-.5)

23

Family members
use/recommended this method

1
(-3.1)

5
(3.9)

0
(-.7)

6

Tastes better

9
(-.3)

2
(-.4)

2
(1.2)

13

Is easily accessible

34
(3.2)

2
(-2.4)

0
(-1.8)

36

Is less expensive

4
(1.2)

0
(-1.0)

0
(-.6)

4

Is more discreet

2
(-4.5)

7
(3.4)

3
(2.5)

12

Other

2
0
1
(-.2)
(-.9)
(1.8)
Total
187
52
18
Note. Adjusted residuals appear in parentheses below observed frequencies.

3
257
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Descriptive statistics were reported for each method of ingestion used 25% or
more of the time, due to having low frequencies across many different cells. For
smoking, more participants reported reasons for use of “stronger intoxication effect” (n =
43), “effects last longer” (n =46), and “is easily accessible” (n =37). More participants
reported certain reasons for using vaping as a method of ingestion including “stronger
intoxication effect” (n =9) and “safer to use” (n =9). For oral, more participants reported
reasons for use of “different kind of high” (n =8) and “effects last longer” (n =13).
Regarding dabbing, two participants reported a reason of use of “stronger intoxication
effect.” For topicals, two participants reported their reason of use was due to topicals
being “easily accessible.” A summary of these descriptive statistics can be found in Table
18. Additional reasons described by participants for using smoking, vaping, and oral
methods of ingestion are included in Table 19.
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Table 18
Descriptive results of reason for use for methods of ingestion used 25% or more of the
time
Reason for Use
Method of Ingestion
Smoking
Vaping Dabbing Oral Topical
Different kind of high
22
3
1
8
0
Stronger intoxication effect

43

9

2

6

0

Effects last longer

46

1

1

13

0

Fewer “hits” are necessary

32

7

1

1

0

Safer to use

35

9

1

1

0

Less side effects

17

5

0

2

0

Friends use/recommended this
method
Family members
use/recommended this method
Tastes better

25

7

1

1

1

6

5

0

1

0

10

1

0

6

0

Is easily accessible

37

3

0

1

2

Is less expensive

4

1

1

0

0

Is more discreet

6

7

0

1

0

Other

9

1

0

0

0

Total

292

60

8

41

3
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Table 19
Additional reasons reported by participants for using certain methods of ingestion
Method of Ingestion/Reason
Smoking
Able to just light it once and smoke casually
Because I enjoy the act of smoking and it’s great to share when you smoke
with friends!
Convenience
Enjoy the experience of rolling and smoking
Easy to share with friends, long lasting, and when you’re in the mood for a
change, the taste is nice
It’s fast
Easiest and quickest
I enjoy smoking and it is easy to sit on a joint and smoke it for 10-15
minutes as a source of engagement and to get high
Is comfortable
It’s comfortable and convenient
Joint [sic] get you just as high if not higher than blunts and take less weed
Social with friends
Vaping
It’s weak
Oral
I don’t need to keep smoking anything I just take on edible and I’m good for
a couple of hours
More of a physical high—helps with scoliosis back pain
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CHAPTER V
DISCUSSION
This cross-sectional exploratory study aimed to examine current trends and
associated problems related to marijuana ingestion among young adult marijuana users.
Research questions addressed by this study included understanding the relationship
between methods of marijuana ingestion and higher frequency of use, problematic use,
motives for use, and mental health outcomes. It was hypothesized that methods of
ingestion that were more potent or with immediate effects, would lead to increases in
frequency of use, problematic use, negative mental health outcomes, and coping motives
for use due to the stronger and immediate intoxication effects. Additionally, the current
study sought to understand the relationship of methods of marijuana ingestion on
historical and current patterns of use in terms of quantity and transitions in methods over
the last five years. Methods of ingestion that were more potent with immediate effects
were hypothesized to be related to heavy/chronic and escalating marijuana use
trajectories. These same marijuana use trajectories were hypothesized to be related to
multiple transitions in method of ingestion over the five years measured in this study.
Contextual factors including availability and awareness of methods were examined. It
was hypothesized that primary method of ingestion may be influenced by perceived ease
of access. Furthermore, endorsed reasons for using certain methods of ingestion were
investigated to understand differences across methods of marijuana ingestion. It was
hypothesized that certain methods of ingestion (e.g. smoking and vaping) would be
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related to endorsed reasons regarding the intoxication effect, while oral methods of
ingestion would be related to discrete or better tasting endorsed reasons for use.
Two hundred sixty-one (100%) of the participants in this study reported using
marijuana in the last 30 days, per eligibility requirements. Sixty-two (23.7%) participants
reported using marijuana on a daily or near daily basis, which is lower than the
proportion (35.4%) of heavy past-month users reported by the National Academies of
Science, Engineering, and Medicine (2017). The mean age of onset for the current sample
was 17.66, which is similar to the age of onset (between 18 to 19 years) found across
multiple countries (Degenhardt et al., 2008). Participants in the current study endorsed a
variety of primary methods of ingestion as well as primary forms of marijuana ingested.
The variety in method of ingestion and marijuana forms used may be partially influenced
by marijuana dispensaries or retail stores that are increasing the variety of products
available to consumers (Borodovsky et al., 2016; Pacula et al., 2014; Pacula et al., 2015),
as 88.5% of the participants in this study lived in a state where marijuana was medically
or recreationally legal.
In this study neither problematic use nor frequency of use were found to be
significantly related to method of ingestion after controlling for gender, age, race, and
level of education. The lack of relationship between method of ingestion and frequency
may be related to the fact that previous research has found that method of ingestion, in
combination with dose or potency, influence marijuana’s subjective effects (Budney &
Borodovsky, 2017). Because some methods have faster effects, individuals may be able
to use less frequently and still achieve the same effects one might achieve with higher
dosage levels (referred to as “self-titration”). Only 23.7% of participants reported using
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marijuana on a daily or near daily basis, which is lower than what has been previously
found (35.4%; National Academies of Science, Engineering, and Medicine, 2017). This
lower than expected frequency (as evidenced by a moderate negative skewness) could
have influenced the effect of frequency of use over the last 30 days in this study, as well
as ultimately problematic use, due to higher frequency of use being related to increased
problematic use, although variability in days used was high. Furthermore, the current
study had lower portions of participants that endorsed using more potent methods of
ingestion (i.e., dabbing). These lower numbers could have impacted the effect of
problematic use, as emerging research is finding concentrates are related to problematic
use (e.g. Meier, 2017). If the current sample had included a greater number of persons
who dabbed as their primary method of use, some effect related to frequency and
problematic use could have been observed. Knowing if method of ingestion is related to
problematic use can be used to influence regulatory processes in states to determine how
products can be created, distributed, and accessed, which can influence progressions to
problematic use and potentially mitigate negative outcomes (Budney & Borodovsky,
2017). Additionally, information regarding methods of ingestion and their effect on
problematic use can be utilized in prevention and intervention programs across all ages,
to continue to tailor and improve them. This can decrease the negative effects these
methods could have by starting prevention programs and educating youth about possible
increased negative effects associated with certain methods of ingestion.
Participants in the current study reported a variety of motives for using marijuana,
however, method of ingestion was not significantly related to these motives (i.e.
enjoyment, conformity, coping, experimentation, altered perceptions, and availability)
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after controlling for gender, age, race, level of education, frequency of use over the last
30 days, and problematic use. The current study utilized motives that are often found to
be related to marijuana use in past studies and sought to understand if method of
ingestion was related to specific motives for using marijuana. Past research has focused
mostly on delineating the motives, how motives vary both between and within
individuals, and motives’ relationship to frequency of use as well as problematic use;
however, no past research has sought to understand the relationship between motives and
methods of ingestion (Bonn-Miller et al., 2007). Past research has found that enjoyment,
altered perception, and conformity motives were associated with increased frequency of
marijuana use (Bonn-Miller et al., 2007; Davis et al., 2018; Lee et al., 2009).
Furthermore, coping motives have been shown to be related to problem marijuana use
(Phillips et al., 2017). Method of ingestion has the potential to be related to motives for
use as individuals’ motives can differ depending on the method (e.g. smoking as a more
social method versus vaping for altered perception due to a stronger intoxication effect).
The current study offers preliminary evidence that method of ingestion is not related to
motives generally; however, it is unclear whether participants might change their method
of ingestion within-the-moment based on fluctuating motives. This finding is important
as past studies have shown certain motives for marijuana use are related to increased risk
across many psychosocial factors. It is critical to continue to delineate how motives for
marijuana use vary both between and within individuals.
Method of ingestion was not significantly related to mental health outcomes, after
controlling for gender, age, race, level of education, frequency of use over the last 30
days, and problematic use. Past literature has shown that while marijuana use has been
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associated with increased risk of anxiety, depression, and lower satisfaction with life, the
literature is mixed (Brook et al., 2013; Fergusson & Boden, 2008; Patton et al., 2002) and
many studies do not adequately control for confounding variables (Moore et al., 2007).
However, the current study sought to understand if method of ingestion could be a
variable that increases risk for depression and anxiety above and beyond marijuana use
itself, due to certain high potency forms of marijuana being associated with particular
methods of ingestion (e.g., dabbing). Unfortunately, persons using the most potent
method (i.e., dabbing) were not recruited adequately for the study, making it difficult to
answer this question. Due to the variability of THC levels across different methods of
ingestion, it is possible that methods with higher intoxication effects can have a greater
effect on mental health. Additional research is needed to understand the complicated
relationship between marijuana use and mental health outcomes. Understanding the
relationship between marijuana use and mental health is important due to the increasingly
positive attitudes towards marijuana in the United States (Gallup, 2017) and the rise of
legalization of marijuana for medicinal and recreational purposes.
The current study sought to understand the relationship between of method of
ingestion and historic marijuana use frequency trajectories. Research regarding marijuana
use trajectories is important to understand factors related to long-term marijuana use, and
to help identify individuals who will phase out of substance use versus those who escalate
to regular and heavy use. The current study found four trajectories of use based on
frequency, which is commensurate with previous research that has historically found
between three and seven developmental trajectory patterns of marijuana use (e.g. Homel
et al., 2014; Schulenberg et al., 2005; Terry-McElrath et al., 2017; Windle & Wiesner,
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2004). Specifically, the current study found trajectory classes that were similar to those
found by Passarotti and colleagues (2015). They found trajectory classes of never/nonusers (33%), low users (29%), medium users (24%), high users (8%), and escalating
users (17%). While this study did not include any non-users of marijuana, the remaining
trajectory classes are similar. The current study found comparable numbers with
moderate (26.5%) and low users (15.6%); however, it was found that more participants
classified as escalating (40.1%) and heavy users (17.9%). Heavy users in the current
study comprised of participants who used daily or more than once per day across the five
years measured. Moderate and low users included participants who used a few times per
month and a few times per year, respectively. Regarding escalators, these participants
reported no or infrequent use at the beginning of the five years measured and transitioned
to daily or more than once per day use near the end. The higher numbers of participants
classified as escalating users is potentially related to average age of onset of the sample
(ages 18 to 25) being 17.66. Many users were answering questions related to use after
initiating use, with many having increases in frequency of use over the last five years as
indicated by the high percentage of participants who were escalators. After deriving the
classes, additional analyses did not indicate significant relationships between trajectory
class and method of marijuana ingestion nor trajectory class and switching of method of
ingestion over the last five years. These findings are important as risk factors for chronic,
heavy, and escalating users need to be understood in the continually changing legal
climate of marijuana in the United States. Individuals who fall within a higher-use
trajectory experience increased negative short- and long- term outcomes associated with
marijuana use. Continued research on the association of method of marijuana ingestion
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and its relationship with developmental use trajectories is needed to increase
understanding of negative consequences related to marijuana use and for public health
planning (Tucker et al., 2005). Through this public health planning, prevention and
intervention strategies can be targeted to youth who show higher numbers of risk factors
(e.g., gender, peer influence, parental education, delinquency, emotional dysregulation)
that can affect the marijuana use trajectory they may fall with-in. Knowledge of these
specific factors can allow for more targeted interventions for smaller groups of youth,
while still providing general prevention and intervention strategies for all youth possibly,
leading to a greater impact of the prevention and intervention strategies.
Contextual factors including availability or awareness of methods were evaluated
by the current study. No significant relationship between method of ingestion and state
legality of marijuana was found. This lack of relationship could be related to a variety of
methods of ingestion already being available to marijuana users. However, state legality
was significantly related to the source of marijuana (e.g. purchased from retail store,
dealer, friend, etc.). This indicates that state legality is related to the source of where
marijuana is purchased, although many participants reported purchasing from informal
sources, even in states with medical and recreational marijuana laws. These findings are
important as they offer preliminary evidence of the relationship between legal status of
marijuana and its effect on purchasing outcomes. Higher numbers of retail outlets
available to purchase marijuana can lead to higher availability of varieties of methods of
ingestion and types of marijuana through lowering travel time and cost of transportation
(Budney & Borodovsky, 2017). The current study supports the idea that more retail
outlets lead to higher availability of methods and adds that legal status also significantly
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affects where the marijuana is purchased. Previous research has found dispensaries per
square mile to be cross-sectionally associated with increases in marijuana hospitalizations
with a marijuana abuse/dependence code (Mair et al., 2015). Higher availability of
methods of ingestion and types of marijuana has the potential to make it easier for youth
to access marijuana. Interestingly, the current study found more than expected
participants in states where marijuana is illegal purchased products from medical
dispensaries. This indicates that consumers are potentially crossing state lines to purchase
products. Due to the participants not listing the states that the marijuana was purchased, it
is difficult to say if the states allow access of medical marijuana for out-of-state residents.
The crossing of state lines to purchase from a retail outlet, ultimately can be viewed as a
safer, but illegal—especially if out-of-state purchases are not legal, alternative to
purchasing from an informal source as retail outlets have regulations for products. As
previously mentioned regarding long-term effects of marijuana use, 16% of e-cigarette,
or vaping, product use-associated lung injury (EVALI) patients reported acquiring
products from retail outlets, while 78% acquired them from informal sources (e.g.,
family, friends, dealers; Centers for Disease Control and Prevention, 2020). The current
study found in states with only medicinal laws (not recreational), more participants (n =
121) purchased or were given marijuana from informal sources than retail outlets (n =
31). While there may be retail outlets that provide safer products, due to regulations,
many individuals are still purchasing marijuana from informal sources that do not have
regulations. These informal sources have the potential to be dangerous, due to the lack of
regulation.
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The current study found some significant relationships between methods of
marijuana ingestion and perceived ease of access. In states where marijuana was illegal or
only medicinally legal, participants reported higher odds of perceived difficulty accessing
bongs, vaporizers, dab rigs, edibles, and topicals. The current study supports the idea that
increased retail outlets can influence perceived availability as well as diversity of
methods of ingestion and products (Budney & Borodovsky, 2017). Odds of perceiving
difficulty in obtaining dab rigs was slightly lower for participants in states where
marijuana is illegal compared to medicinally legal. Additionally, as education level
increased, participants were more likely to report difficulty in finding certain methods of
ingestion. Regarding ethnicity, Caucasian participants had a lower perceived difficulty in
obtaining certain methods of ingestion than participants from other ethnicities. This
finding could in part, be related to differences in portions of participants from varying
ethnic backgrounds across state legality grouping (e.g. more Caucasian in states with
recreational marijuana laws). Another potential influence for this finding could be related
to participants located in rural versus urban areas, with rural participants from varying
ethnic backgrounds requiring increased travel times to access different methods of
ingestion. Continued research in availability and ease of access are needed as the
prevalence of marijuana outlets as well as information across media forms (e.g. social
media, radio) continues to increase. Research has found online posts regarding certain
methods of ingestion (e.g. edibles, dabs) to be positive in nature, normalizing marijuana
use, and higher in frequency in states that allow recreational use of marijuana (CavazosRehg et al., 2018; Daniulaityte et al., 2015; Lamy et al., 2016; Lamy et al., 2018). As
social acceptability and legalization of marijuana continue to shift, research on the
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availability and awareness of different methods of ingestion is needed to identify
emerging trends due to changing marijuana legalization policies, to inform timely
prevention and policy measures, and minimize potential dangers of certain methods of
use to consumers (Daniulaityte et al., 2015; Gourdet et al., 2017; Schauer et al., 2016).
Using emerging trends to inform prevention strategies and policy measures can affect
youth’s awareness of the potential dangers of certain methods (e.g. concentrates being
related to problematic use).
The current study sought to understand reasons for transitioning methods of
ingestion as well as reasons for using certain methods of ingestion. It was found that the
relationship between primary method of ingestion and reason for use was significant,
meaning that participants were endorsing specific reasons for using certain methods. This
echoes previous research that has found individuals endorse specific reasons for liking
certain methods of ingestion. These findings have been important as they have
highlighted specific reasons for using that are associated with potency and stronger
intoxication effect of certain methods (Loflin & Earleywine, 2014). Similarly, the current
study found that “stronger intoxication effect,” “fewer “hits” necessary,” and “effects last
longer” were common reasons reported across most methods endorsed in this study. For
participants who endorsed using smoking methods of ingestion, common reasons for use
were “stronger intoxication effect,” “effects last longer,” “fewer “hits” necessary,”
“different kind of high,” and “is easily accessible.” Participants who used vaping methods
of ingestion endorsed reasons for use related to “safer to use,” “less side effects,” “family
members use/recommended it,” “is more discreet,” “stronger intoxication effect,” and
“recommended/used by friends.” For oral methods of ingestion, participants endorsed

103
reasons for use including “effects last longer,” “different kind of high,” “more discreet,”
“stronger intoxication effect,” and “less side effects.” Findings of this nature suggest that
endorsed reasons for using certain methods could be a factor related to a higher risk for
developing substance use disorders due to reasons being related to stronger intoxication
effects. Interestingly, participants endorsed “safer to use” and “less side effects” as
reasons for using vaping methods of ingestion. This contradicts emerging research from
the CDC (2020) indicating that vaping is related to acute lung distress, particularly when
cartridges are bought from informal sources, although vaping is still considered a safer
alternative to smoking due to lower levels of carcinogens. Research is still emerging on
long-term effects of vaping. Continued research, with large sample sizes is needed in this
area to delineate if individuals endorse specific reasons for transitioning between
methods or using certain methods. Additionally, continued research in endorsed reason
for using certain methods of ingestion is important as methods with more positive
perceptions may influence patterns of use in the United States (Lee et al., 2016).
Currently, research is extremely limited in this area and future work needs to continue to
focus on delineating endorsed reasons for using certain methods of ingestion, as well as
how these reasons vary between methods of ingestion and individuals. This research can
be used to guide regulatory processes in states to determine how products can be created,
distributed, and accessed to ensure safety in diverse methods of ingestion (Budney &
Borodovsky, 2017).
Limitations
The current research study has several limitations. First, participants of the current
study were self-selected among people recruited online, which increases potential for
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non-generalizable results. Compared to U.S. census data the current study should be
interpreted with caution due to differences in gender and ethnicity; however, compared to
some previous research in the field of marijuana studies this study was similar in reported
ethnicities of participants. As the survey was anonymous it was not possible to identify
repeat respondents. A significant limitation to the current study was the cross-sectional
nature of the data collected. To understand causal relationships between methods of
marijuana ingestion and associated problems, longitudinal studies are required that
measure participants over a range of use (e.g. youth to adulthood).
Statistically, limitations of the current study included large differences in the
numbers of participants for each level of the MANCOVA used, which violates one of the
assumptions of this statistical procedure and resulted in the removal of dabbing as a
method of ingestion. Due to the number of methods endorsed by participants as well as
the number of reasons for using certain methods endorsed, there were analyses that did
not have sufficient distribution across the cells to be analyzed, leading to some
information being presented in a descriptive manner in the current study. Continued
research in reasons for using certain methods is needed, as a broad range of reasons were
endorsed for each method, including many new reasons that were not included in the
original development of the measure for the current study.
Finally, increased numbers of participants are necessary to fully understand
endorsed reasons for primary method of ingestion as well as transitions in methods due to
the variety of reasons that are endorsed across individuals. Certain methods that are more
potent with immediate effects (e.g. dabbing) had low occurrence rates within this sample,
which limits the conclusions that can be drawn regarding their effects on associated
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problems of use (e.g. problematic use, frequency of use). Due to this low frequency,
participants should have been over-sampled to ensure that this method of ingestion could
have been included in the analyses.
Future Directions
Future research should continue to delineate associations of methods of marijuana
ingestion in the continually changing legalization climate in the United States. As
marijuana is the most commonly used, federally illicit drug, it becomes increasingly
important to understand factors related to increased marijuana use, as it is associated with
a plethora of negative outcomes. During the time this dissertation was being drafted,
marijuana use for those ages 12 and older increased by nearly 20 million individuals in
one year (Substance Abuse and Mental Health Services Administration, 2018; Substance
Abuse and Mental Health Services Administration, 2019). Research with higher numbers
of participants is needed to try and understand methods of ingestion that are being used
less frequently (e.g. dabs) but have the potential to have increased negative outcomes due
to potency and immediate effects. It is imperative to continue to identify short- and longterm effects of products with high potency and immediate effects as research is currently
lacking.
The developmental course of marijuana use should continue to be monitored, with
increased focus on methods of ingestion as a contextual factor that can affect the
trajectory. While this study did not find significant results in this area, it was cross
sectional in nature, which can result in participants who might not have been able to
accurately report marijuana use information over the past five years as compared to
participants in longitudinal designs. In this ever-changing legal climate, methods will
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continue to be diversified with easier access for younger and younger individuals. This
can affect the trajectory of use for these individuals. Therefore, it is important to try and
understand factors related to these negative trajectories as soon as possible, because
research is lacking behind this ever-changing legalization climate. It is imperative to
understand negative outcomes to influence safety standards and regulations (Benjamin &
Fossler, 2016; Cao et al., 2016).
In this study, participants endorsed a variety of reasons for using certain methods
of ingestion, with many participants writing in new reasons not originally included.
Future research needs to continue to understand these reasons for use, and to understand
if they are related to any associated problems (e.g. problematic use, negative mental
health outcomes) for users. This is important research as it can help understand reasons
why someone may choose a certain method (e.g. safer, stronger intoxication effect),
because positive perceptions of methods of ingestion that are readily available may
influence patterns of use (Lee et al., 2016).
Retail outlets for marijuana are motivated to increase sales through increasing the
variety of products available to consumers (Borodovsky et al., 2016; Pacula et al., 2014;
Pacula et al., 2015), however, many products lack empirically-based packaging
regulations, proactive ingredient levels, and safety standards (Benjamin & Fossler, 2016;
Cao et al., 2016). The current study found that high numbers of participants were
obtaining marijuana from informal sources (e.g. friends, family, dealers). It is important
to continue to understand where marijuana is being purchased as the CDC has found that
many patients diagnosed with EVALI had purchased marijuana from informal sources
(CDC, 2020). This relationship between EVALI and informal sources of marijuana
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highlights the importance of empirically based packaging regulation and safety standards.
Recently, a family was arrested for having more than 30,000 vape cartridges of THC as
well as nearly 100,000 mason jars filled with THC oil (Salo, 2019, October 2). This
family is just one example of an informal source of marijuana, with limited to no
regulation and safety standards. As access to a variety of methods of marijuana ingestion
continues to grow, a body of evidence is necessary to guide, prioritize, and evaluate
public health and policy efforts regarding marijuana (Allen et al., 2017).
Conclusion
Overall, the current study found that methods of ingestion (e.g. smoking, vaping,
oral) were not related to problematic use nor frequency of use. Methods of ingestion were
found to not be significantly related to motives for marijuana use (i.e. enjoyment,
conformity, coping, experimentation, altered perceptions, and availability). Furthermore,
this study found that methods of ingestion were not significantly related to mental health
outcomes (i.e. anxiety and depression). The current study was able to classify participants
into four trajectory use classes; however, the classes were not significantly related to
method of ingestion. Additionally, differences in individuals transitioning between
methods were found, resulting in two transition classes, however these were not
significantly related to trajectory classes based on frequency of use and quantity. No
relationship was found between state legality status and current method of ingestion;
however, state legality status was related to perceived difficulty of obtaining vaporizers,
dab rigs, edibles, and topicals. Furthermore, it was found that state legality significantly
affected where marijuana was purchased, with many more participants than expected in
medicinally legal states continuing to purchase from informal sources.
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The current study found that particular reasons for use are endorsed more
frequently for certain methods. Specifically, for smoking more common reasons for using
included: “stronger intoxication effect,” “effects last longer,” “fewer “hits” necessary,”
“different kind of high,” and “is easily accessible.” For vaping methods of ingestion
participants endorsed reasons of “safer to use,” “less side effects,” “family members
use/recommended it,” “is more discreet,” “stronger intoxication effect,” and
“recommended/used by friends.” Finally, for oral methods of ingestion, participants
endorsed reasons for use including “effects last longer,” “different kind of high,” “more
discreet,” “stronger intoxication effect,” and “less side effects.”
In conclusion, while the current study found some preliminary evidence related to
methods of ingestion, as well as differences in endorsed reasons for use for certain
methods of ingestion, additional research is needed to establish other factors that may
relate to methods of ingestion. Methods of ingestion should be considered when
developing prevention strategies as certain methods could be associated with higher rates
of negative short- and long-term consequences associated with marijuana use. Methods of
marijuana ingestion have the potential to influence use, and research is needed to
understand these possible influences to guide intervention strategies as well as public
policy.
As a school psychologist, working within the school system, increased knowledge
regarding the effect of methods of ingestion and contextual factors with youth can be
critical in helping schools choose effective prevention and intervention strategies. Some
strategies that could be useful would be general screening, for all students, that seeks to
understand general substance use trends within the school. Based on these screenings,
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intervention strategies can be tailored to provide youth with information to help increase
their knowledge of potential dangers to use (e.g. formal versus informal sources of
marijuana, short- and long- term consequence of use). Additionally, youth who show
many risk factors related to chronic or heavy use trajectories can receive more specific
interventions (e.g. small group or individual) tailored to mitigating some of these risk
factors (e.g. emotional dysregulation, peer influence, college attainment). Schools are
positioned in a way to influence many youth across the nation, given that the average age
of onset for this sample was 17.66. Meaning, there are many youth who are initiating use
before the age of 17 who can be affected by strategies utilized in schools.
Furthermore, for school psychologists working in other settings (e.g., private
practice, integrated primary care) the use of screening tools can be equally beneficial.
While school psychologists in these settings are seeing fewer youth, screening for
substance use is equally as important. Youth and their families who present to these
settings are seeking intervention services for their family. It is critical to conduct
consultation interviews that seek to understand parental as well as youth risk factors, and
screen for substance use. Collecting all this information is critical to implement targeted
intervention strategies before the youth’s substance use becomes problematic. Families
and youth may not report substance use as the reason for seeking services, but it is critical
to screen for substance use as it has many short- and long-term effects that can be related
to why a family is presenting for services (e.g. changes in memory, learning, negative
emotionality, psychotic symptoms). Furthermore, in states where marijuana is legal and
there are more retail outlets for purchasing, it may be critical to screen all youth who
present for treatment as higher retail outlet density has been associated with a younger

110
age of onset for certain methods of ingestion (Borodovsky et al., 2017). With increasing
numbers of states legalizing marijuana for medical as well as recreational use, a thorough
understanding of methods of ingestion is necessary as they are becoming increasingly
diversified and accessible. This research can identify any potential negative outcomes
that can arise from legalization of marijuana as well as guide, prioritize, and evaluate
public health and policy efforts.
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SURVEY QUESTIONS
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Survey Questions
Participants will first review a description of the study and informed consent. Following
this, they will be prompted to indicate their agreement to participate.
Q1 ELECTRONIC CONSENT: Please select your choice below. You may print a copy
of this consent for your records. Clicking on the “Agree” button indicates that:
• You have read the above information
• You voluntarily agree to participate
• You are 18 years of age or older and use marijuana at least monthly
o Agree
o Disagree
Q2 Are you age 18 or older?
o Yes
o No
Q3 Do you currently use marijuana, at least monthly?
o Yes
o No
Demographics
Q4 How old are you?
Q5 Which term best describes your ethnicity?
o Not Hispanic or Latino
o Hispanic/Latino
Q6 Please indicate your race/ethnicity? (check all that apply)
o Caucasian / White
o Black
o Native American / Alaskan Native
o Biracial / Multiracial (Please Specify) _____________
o Asian
o Pacific Islander / Native Hawaiian
o Hispanic / Latino
o Other (Please Specify) ___________
Q7 How would you characterize your current relationship/marital status?
o Single
o Married / Civil Union/ Living together long term
o Seriously dating / exclusive relationship with a partner
o Separated / Divorced
o Widowed
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Q8 What is your sexual orientation?
o Gay Male
o Lesbian
o Bisexual
o Heterosexual / Straight
o Other (Please Specify) ___________
o Prefer not to respond
Q9 Would you consider the area you live in to be rural or urban?
o Rural (<2,500 population)
o Urban Cluster (2,500-50,000 population)
o Urban (>50,000 population)
Q10 Which of the following best describes your current living situation?
o Live alone in my own home (e.g., house, apartment, etc.)
o Live in a household with other people
o Live in university housing
o Live in a residential facility where meals and household help are routinely
provided by paid staff (or could be if requested)
o Temporarily staying with a relative or friend
o Temporarily staying in a shelter or are homeless
o Other __________
Q11 Are you currently working? (check all that apply)
Yes, full time (35 or more hours per week)
Yes, part time (less than 35 hours per week)
No, currently unemployed
Receiving disability (SSI)
In school part-time
In school full-time
Retired
Other: __________
Q12 Please describe the highest level of education you have attained.
o Less than 12th grade and No GED
o GED
o High school diploma
o Some College
o Bachelor’s degree
o Advanced graduate degree (e.g. Master’s, Law Degree, MD, PhD, etc.)
o Don’t know
Q13 Please describe the highest level of education attained by your mom.
o Less than 12th grade and No GED
o GED
o High school diploma
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o
o
o
o

Some College
Bachelor’s degree
Advanced graduate degree (e.g. Master’s, Law Degree, MD, PhD, etc.)
Don’t know

Q14 Please describe the highest level of education attained by your dad.
o Less than 12th grade and No GED
o GED
o High school diploma
o Some College
o Bachelor’s degree
o Advanced graduate degree (e.g. Master’s, Law Degree, MD, PhD, etc.)
o Don’t know
Q15 How would you describe your family’s income when you were a young teen (e.g. 12
– 15 old)? Please include your best guess based upon all income earned by your mom,
dad, guardian, etc. for the WHOLE household. Total family income was:
o Under $20,000 per year
o Between $20,000--$30,000 per year
o Between $20,000--$30,000 per year
o Between $30,000--$40,000 per year
o Between $40,000--$60,000 per year
o Between $60,000--$80,000 per year
o Between $80,000--$100,000 per year
o Between $100,000--$150,000 per year
o Between $150,000--$200,000 per year
o Between $200,000--$250,000 per year
o Above $250,000 per year
Q16 How would you describe your income currently?
o Under $20,000 per year
o Between $20,000--$30,000 per year
o Between $20,000--$30,000 per year
o Between $30,000--$40,000 per year
o Between $40,000--$60,000 per year
o Between $60,000--$80,000 per year
o Between $80,000--$100,000 per year
o Between $100,000--$150,000 per year
o Between $150,000--$200,000 per year
o Between $200,000--$250,000 per year
o Above $250,000 per year
Q17 Did any members of your immediate family abuse drugs or alcohol while you were
growing up? If yes, select the individuals and add others as they apply.
N/A
Father
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Mother
Brother 1
Sister 1
Other 1 (write in relation of person): __________
Other 2 (write in relation of person): __________
Q18 Please rate the severity of drug use by the immediate family members you indicated
in the previous question?
No
Mild (had some
Moderate
Severe (experienced many
consequences
negative
(experienced
negative consequences
consequences, but
multiple negative
[e.g., went to treatment
nothing severe
consequences and
multiple times, had legal
went to treatment)
trouble])
Father
o
o
o
o
Mother
o
o
o
o
Brother
o
o
o
o
Sister
o
o
o
o
Other 1
o
o
o
o
Other 2
o
o
o
o
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Daily Sessions, Frequency, Age of Onset, and Quantity of Cannabis Use Inventory
(DFAQ)
DFAQ_1 Which of the following best captures when you last used marijuana?
o 3 weeks ago
o 2 weeks age
o Last week
o This week
o Yesterday
o Today
o I am currently high
DFAQ_1b How high are you right now?
o I am not high at all
o I am a little bit high
o I am moderately high
o I am very high
o I am extremely high
DFAQ_2 Which of the following best captures the average frequency you currently use
marijuana?
o I do not currently use marijuana
o Less than once a year
o Once a year
o Once every 3 to 6 months (2-4 times per year)
o Once every 2 months (6 times per year)
o Once a month
o 2—3 time a month
o Once a week
o Twice a week
o 3—4 times a week
o 5—6 times a week
o Once a day
o More than once a day
DFAQ_3 Which of the following best captures how long you have been using marijuana
at this frequency?
o Less than 1 month
o 1—3 months
o 3—6 months
o 6—9 months
o 9—12 months
o 1—2 years
o 2—3 years
o 3—5 years
o 5—10 years
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o 15-20 years
o More than 20 years
DFAQ_4 Before the period of time you indicated above, how frequency did you use
marijuana?
o I did not use marijuana
o Less than once a year
o Once every 3 to 6 months (2-4 times per year)
o Once every 2 months (6 times per year)
o Once a month
o 2—3 times a month
o Once a week
o Twice a week
o 3—4 times a week
o 5—6 times a week
o Once a day
o More than once a day
DFAQ_5 How many days of the past week did you use marijuana?
o 0 days
o 1 days
o 2 days
o 3 days
o 4 days
o 5 days
o 6 days
o 7 days
DFAQ_6 Approximately how many days (0-30) of the past month did you use
marijuana?
DFAQ_8 Which of the following best captures your pattern of marijuana use throughout
the week?
o I do not use marijuana at all
o I only use marijuana on weekends
o I only use marijuana on weekdays
o I use marijuana on BOTH weekends and weekdays
DFAQ_9 How many hours after waking up do you typically first use marijuana?
o I do not use marijuana at all
o 12—18 hours after waking up
o 9—12 hours after waking up
o 6—9 hours after waking up
o 3—6 hours after waking up
o 1—3 hours after waking up
o Within 1 hours of waking up

148
o With 1/2 hour of waking up
o Immediately upon waking up
DFAQ_10 How many times a day, on a typical weekday, do you use marijuana?
DFAQ_11 How many times a day, on a typical weekend, do you use marijuana?
DFAQ_12 What is the primary method you use to ingest marijuana?
o Joint
o Blunts (cigar sized joints)
o Hand pipe
o Bong (water pipe)
o Hookah
o Vaporizer (e.g. Volcano, vape pen)
o E-cigarette device (sold for nicotine)
o Dab rig (e.g. oil rig, hot knives)
o Edibles
o Topicals (e.g., lotions, creams)
o Other ___________
DFAQ_13 Which of the following other methods to ingest marijuana do you use
regularly (at least 25% of the time you use marijuana)? [Check all that apply]
Blunts (cigar sized joints)
Hand pipe
Bong (water pipe)
Hookah
Vaporizer (e.g. Volcano, vape pen)
E-cigarette device (sold for nicotine)
Dab rig (e.g. oil rig, hot knives)
Edibles
Topicals (e.g., lotions, creams)
Other ___________
DFAQ_14 What is the primary form of marijuana you use?
o None
o Marijuana (e.g. Flower, Bud, Herb)
o Edibles
o Concentrates (e.g. Oil, Wax, Shatter, Butane Hash Oil)
o Other __________
DFAQ_15 Which other forms of marijuana do you use regularly (at least 25% of the time
you use marijuana)? [Check all that apply]
None
Marijuana (e.g. Flower, Bud, Herb)
Edibles
Concentrates (e.g. Oil, Wax, Shatter, Butane Hash Oil)
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Other __________
DFAQ_image Please use the image below to refer to various quantities of marijuana. The
image is not to scale; the dollar bill is included to help provide size perspective.

DFAQ_16a In a typical session (e.g., a period devoted to using), how much marijuana
(e.g., Flower, Bud, Herd) do you personally use?
o 1/8 gram (0.125)
o 1/4 gram (0.25)
o 1/2 gram (0.5)
o 3/4 gram (0.75)
o 1.0 gram
o 1.5 grams
o 2.0 grams
o 2.5 grams
o 3.0 grams
o 3.5 grams (1/8 ounce)
o 7 grams (1/4 ounce)
o Other __________
o I don’t know
DFAQ_17a On a typical day when you use marijuana (e.g. Flower, Bud, Herb), how
much do you personally use?
o 1/8 gram (0.125)
o 1/4 gram (0.25)
o 1/2 gram (0.5)
o 3/4 gram (0.75)
o 1.0 gram
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o
o
o
o
o
o
o
o

1.5 grams
2.0 grams
2.5 grams
3.0 grams
3.5 grams (1/8 ounce)
7 grams (1/4 ounce)
Other __________
I don’t know

DFAQ_18a How much marijuana (e.g. Flower, Bud, Herb), did you personally use
yesterday?
o 1/8 gram (0.125)
o 1/4 gram (0.25)
o 1/2 gram (0.5)
o 3/4 gram (0.75)
o 1.0 gram
o 1.5 grams
o 2.0 grams
o 2.5 grams
o 3.0 grams
o 3.5 grams (1/8 ounce)
o 7 grams (1/4 ounce)
o Other __________
o I don’t know
DFAQ_19a In a typical week you use marijuana (e.g. Flower, Bud, Herb), how much
marijuana do you personally use?
o 1/8 gram (0.125)
o 1/4 gram (0.25)
o 1/2 gram (0.5)
o 3/4 gram (0.75)
o 1.0 gram
o 1.5 grams
o 2.0 grams
o 2.5 grams
o 3.0 grams
o 3.5 grams (1/8 ounce)
o 7 grams (1/4 ounce)
o Other __________
o I don’t know
DFAQ_20a On a typical day you use marijuana (e.g. Flower, Bud, Herb), how many
sessions (e.g., a period devoted to using) do you have?
DFAQ_21a What is the average THC content/potency of the marijuana (e.g., Flower
Bud, Herb) you typically use?
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o
o
o
o
o
o
o
o

0—4%
5—9%
10—14%
15—19%
20—24%
25—30%
Greater than 30%
I don’t know

DFAQ_16b In a typical session (e.g., a period devoted to using), when you use marijuana
concentrates, how many hits do you personally take?
DFAQ_17b On a typical day you use marijuana concentrates, how many hits do you
personally take?
DFAQ_18b Yesterday, how many hits of marijuana concentrates did you personally
take?
DFAQ_19b In a typical week you use marijuana concentrates, how many grams do you
personally use (Please note that a typical concentrate amount = .08 - .10 grams)?
o .05 grams
o .08 grams
o .10 grams
o .20 grams
o Other __________
o I don’t know
DFAQ_20b On a typical day when you use marijuana concentrates, how many sessions
(e.g. a period devoted to using) do you have?
DFAQ_21b What is the average THC content/potency of the marijuana (e.g., Flower
Bud, Herb) you typically use?
o 0—9%
o 10—19%
o 20—29%
o 30—39%
o 40—49%
o 50—55%
o 60—69%
o 70—79%
o 80—89%
o Greater than 90%
o I don’t know
DFAQ_21c When you eat edibles, how many milligrams of THC do you personally
ingest in a typical session (e.g., period devoted to using)? Note: One serving typically
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includes 10 milligrams. An example would be one gummy bear, which are usually 10
milligrams each.
o 5 milligrams
o 10 milligrams
o 15 milligrams
o 20 milligrams
o Other __________
o I don’t know
DFAQ_21d What type of edible do you typically consume (e.g. cookies, gummy bear,
etc.)?
DFAQ_24 How old were you when you FIRST tried marijuana (in any form)?
DFAQ_23 How many years in total have you used marijuana?
DFAQ_25 Has there been any time in your life when you used marijuana regularly (2 or
more times per month for 6 months or longer)?
o No
o Yes
DFAQ_25b How old were you when you FIRST STARTED using marijuana regularly (2
or more times per month)?
DFAQ_25c Has there been any time in your life when you used marijuana on a daily or
near daily basis for 6 months or longer?
o No
o Yes
DFAQ_25cii How old were you when you FIRST STARTED using marijuana on a daily
or near daily basis?
DFAQ_26 Which of the following best captures the average frequency that you used
marijuana before the age of 16?
o Never
o Less than once a year
o Once every 3 to 6 months (2—4 times per year)
o Once every 2 months (6 times per year)
o Once a month
o 2—3 times a month
o Once a week
o Twice a week
o 3—4 times a week
o 5—6 times a week
o Once a day
o More than once a day
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DFAQ_27 Do you have a prescription to use marijuana for medical purposes?
o No
o Yes
o Yes, but I use it for both medical and recreational purposes
DFAQ_27b Which medical condition(s) do you use marijuana to treat?
o Pain, please describe: __________
o Muscle spasms
o Nausea
o Cancer
o Seizures
o HIV/AIDS
o Glaucoma
o Other, please describe: __________
DFAQ_27c What percentage of the time do you use marijuana for recreational (rather
than medical) purposes?
DFAQ_28 Where do you typically get your marijuana?
o Purchase from retail store/dispensary for those over age 21 (you PERSONALLY
buy it from a retail store/dispensary)
o Purchase from medical dispensary (you PERSONALLY have a medical
marijuana card)
o Purchase from a dealer
o Purchase from a friend
o It’s given to me for free (friend/family)
o I grow my own
o Other __________
DFAQ_29 When you use marijuana, what is the most common strain you use?
o Indica-dominant
o Sativa-dominant
o Hybrid (Indica-dominant)
o Hybrid (Sativa-dominant)
o Hybrid (unsure of breakdown)
o Other __________
o Do not know
DFAQ_30 Do you think the questions up to this point have accurately measured your
current marijuana consumption and your history of marijuana consumption?
o Yes
o No
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DFAQ_30b Please describe in words any aspects of your marijuana use that were not
reflected well in your answers to these questions. What information about your marijuana
use would you like to add?
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Rutgers Marijuana Problem Index
RMPI_1 Different things happen to people while they are using marijuana or because of
their marijuana use. Several of these things are listed below. How many times have the
following happened to you while you were using marijuana or because of using
marijuana during the LAST YEAR?
Never (0) One or two Three to five More than five
times (1)
times (2)
times (3)
Not able to do your
o
o
o
o
homework or study for a
test (1)
Got into fights with other
o
o
o
o
people (friends, relatives,
strangers) (2)
Missed out on other things
o
o
o
o
because you spend too
much money on marijuana
(3)
Went to work or school
o
o
o
o
high from marijuana (4)
Caused shame or
o
o
o
o
embarrassment to
someone (5)
Neglected your
o
o
o
o
responsibilities (6)
Relatives avoided you (7)
o
o
o
o
Felt that you needed more
o
o
o
o
marijuana than you used
to in order to get the same
effect (8)
Tried to control your
o
o
o
o
marijuana use (for
example, used only at
certain times of the day or
in certain places, that is,
tried to change your
pattern of use) (9)
Had withdrawal
o
o
o
o
symptoms, that is, felt
sick because you stopped
or cut down on your
marijuana use (10)
Noticed a change in your
o
o
o
o
personality (11)
Felt you had a problem
o
o
o
o
with marijuana (12)
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RMPI_2 How many times have the following happened to you while you were using
marijuana or because of using marijuana during the LAST YEAR?
Never (0) One or two Three to five More than five
times (1)
times (2)
times (3)
Missed a day (or part of a
o
o
o
o
day) of school or work
(13)
Wanted to stop using
o
o
o
o
marijuana but couldn’t
(14)
Suddenly found yourself
o
o
o
o
in a place that you could
not remember getting to
(15)
Passed out of fainted
o
o
o
o
suddenly (16)
Had a fight, argument or
o
o
o
o
bad feelings with a friend
(17)
Had a fight, argument, or
o
o
o
o
bad feelings with a family
member (18)
Kept using marijuana
o
o
o
o
when you promised
yourself not to (19)
Felt you were going crazy
o
o
o
o
(20)
Has a bad time (21)
o
o
o
o
Felt physically or
o
o
o
o
psychologically dependent
on marijuana (22)
Was told by a friend,
o
o
o
o
neighbor or relative to
stop or cut down on your
marijuana use (23)
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Comprehensive Marijuana Motives Measure
MMQ_1 Please select the FREQUENCY below for each question to indicate how often
you use marijuana in each situation. How often have you used marijuana…
Almost
Seldom Sometimes Often
Almost
never or
(2)
(3)
(4)
always or
never (1)
always (5)
To enjoy the effects of it
o
o
o
o
o
(1)
Because you felt pressure
o
o
o
o
o
from others who do it (2)
To forget your problems
o
o
o
o
o
(3)
Because you were
o
o
o
o
o
experimenting (4)
Because you had nothing
o
o
o
o
o
better to do (5)
Because you were drunk
o
o
o
o
o
(6)
To celebrate (7)
o
o
o
o
o
Because you want to alter
o
o
o
o
o
your perspective (8)
Because it makes you
o
o
o
o
o
more comfortable in an
unfamiliar situation (9)
Because it is safer than
o
o
o
o
o
drinking alcohol (10)
To help you sleep (11)
o
o
o
o
o
Because it is readily
o
o
o
o
o
available (12)
Because you would not
o
o
o
o
o
eat without using
marijuana first (13)
Because it helps you
o
o
o
o
o
enjoy a party (14)
Because it is fun (15)
o
o
o
o
o
Because you didn’t want
o
o
o
o
o
to be the only one not
doing it (16)
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MMQ_2 Please select the FREQUENCY below for each question to indicate how often
you use marijuana in each situation. How often have you used marijuana…
Almost
Seldom Sometimes Often
Almost
never or
(2)
(3)
(4)
always or
never (1)
always (5)
Because you were
o
o
o
o
o
depressed (17)
Because you were curious
o
o
o
o
o
about marijuana (18)
Because it increases your
o
o
o
o
o
appetite (19)
To be sociable (20)
o
o
o
o
o
To relieve boredom (21)
o
o
o
o
o
Because you were under
o
o
o
o
o
the influence of alcohol
(22)
Because it was a special
o
o
o
o
o
day (23)
Because you want to alter
o
o
o
o
o
your perspective (24)
To allow you to think
o
o
o
o
o
differently (25)
To make you feel more
o
o
o
o
o
confident (26)
To help you eat regularly
o
o
o
o
o
(27)
Because it is not a
o
o
o
o
o
dangerous drug (28)
Because it helps make
o
o
o
o
o
napping easier and
enjoyable (29)
Because it helps you
o
o
o
o
o
enjoy food more (30)
Because you can get it for
o
o
o
o
o
free (31)
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MMQ_3 Please select the FREQUENCY below for each question to indicate how often
you use marijuana in each situation. How often have you used marijuana…
Almost
Seldom Sometimes Often
Almost
never or
(2)
(3)
(4)
always or
never (1)
always (5)
To feel good (32)
o
o
o
o
o
To be cool (33)
o
o
o
o
o
Because it makes social
o
o
o
o
o
gathering more fun (34)
To escape from your life
o
o
o
o
o
(35)
To see what it felt like
o
o
o
o
o
(36)
Because you wanted
o
o
o
o
o
something to do (37)
Because it is part of your
o
o
o
o
o
meal routine (38)
Because you had gotten
o
o
o
o
o
drunk and weren’t
thinking about what you
were doing (39)
Because it was a special
o
o
o
o
o
occasion (40)
So you can look at the
o
o
o
o
o
world differently (41)
Because it relaxes you
o
o
o
o
o
when you are in an
insecure situation (42)
Because there are low
o
o
o
o
o
health risks (43)
Because you are having
o
o
o
o
o
problems sleeping (44)
Because it is there (45)
o
o
o
o
o
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Generalized Anxiety Disorder Scale (GAD-7)
GAD-7 Over the LAST 2 WEEKS, how often have you been bothered by the following
problems?
Not at all
Several
More than
Nearly
days
half the days
every day
Feeling nervous, anxious or on
o
o
o
o
edge (1)
Not being able to stop or
o
o
o
o
control worrying (2)
Worrying too much about
o
o
o
o
different things (3)
Trouble relaxing (4)
o
o
o
o
Being so restless that it is hard
o
o
o
o
to sit still (5)
Becoming easily annoyed or
o
o
o
o
irritable (6)
Feeling afraid as if something
o
o
o
o
awful might happen (7)
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Patient Health Questionnaire Depression Scale (PHQ-8)
PHQ-8 Over the LAST 2 WEEKS, how often have you been bothered by the following
problems?
Not at
Several
More than
Nearly
all
days
half the days
every day
Little interest or pleasure in
o
o
o
o
doing things (1)
Feeling down, depressed, or
o
o
o
o
hopeless (2)
Trouble falling or staying
o
o
o
o
asleep, or sleeping too much (3)
Feeling tired or having little
o
o
o
o
energy (4)
Poor appetite or overeating (5)
o
o
o
o
Feeling bad about yourself –or
o
o
o
o
that you are a failure or have let
yourself or your family down
(6)
Trouble concentrating on
o
o
o
o
things, such as reading the
newspaper or watching
television (7)
Moving or speaking so slowly
o
o
o
o
that other people could have
noticed? Or the opposite –being
so fidgety or restless that you
have been moving around a lot
more than usual (8)
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Patterns and Transitions in Marijuana Use
In the next few questions you will be asked about your marijuana use over the last five
years. For each year you will be asked to estimate the frequency of your use, the amount
used on a typical day (if you are able to recall), the primary form of marijuana used, the
primary method of ingestion used, and if your primary method changed from one year to
the next. If your primary method did not change, select no. If you did not use marijuana
at all for a specific year, simply choose “did not use this year” as the response for all
questions.
Trajectories_1 For each of the following questions, please think about the ENTIRE year
listed on the left when answering each question.
Year
State of Frequency
Primary Additional
Residence
of use
form of
forms of
marijuana marijuana
used
used
2018
o
o
o
o
2017
o
o
o
o
2016
o
o
o
o
2015
o
o
o
o
2014
o
o
o
o

Year

2018
2017
2016
2015
2014

Amount
Used on a
typical day
o
o
o
o
o

Primary
method
used
o
o
o
o
o

Additional
methods
used
o
o
o
o
o

Trajectories_2 Response options for State of Residence
(Select from drop down box of all U.S. states.)
Trajectories_3 Response options for Frequency of use:
o Did not use this year
o Less than once a year
o Once every 3 to 6 months (2—4 times per year)
o Once every 2 months (6 times per year)
o Once a month
o 2—3 times a month
o Once a week
o Twice a week
o 3—4 times a week
o 5—6 times a week

Method
change

Why did it
change?

o
o
o
o
o

o
o
o
o
o
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o Once a day
o More than once a day
Trajectories_4 Response options for Primary form of marijuana used:
o Did not use this year
o Marijuana (e.g. Flower, Bud, Herb)
o Edibles
o Concentrates (e.g. Oil, Wax, Shatter, Butane Hash Oil)
o Other
Trajectories_5 Response options for Additional forms of marijuana used:
o Did not use this year
o Marijuana (e.g. Flower, Bud, Herb)
o Edibles
o Concentrates (e.g. Oil, Wax, Shatter, Butane Hash Oil)
o Other
Trajectories_6 Response options for Amount of marijuana (flower) used on a typical
day:
o Did not use this year
o 1/8 gram (0.125)
o 1/4 gram (0.25)
o 1/2 gram (0.5)
o 3/4 gram (0.75)
o 1.0 gram
o 1.5 grams
o 2.0 grams
o 2.5 grams
o 3.0 grams
o 3.5 grams (1/8 ounce)
o 7 grams (1/4 ounce)
o Other __________
o I don’t know
Trajectories_7 Response options for Amount of edibles used on a typical day:
o 5 milligrams
o 10 milligrams
o 15 milligrams
o 20 milligrams
o Other __________
o I don’t know
Trajectories_8 Response options for Amount of concentrates used on a typical day:
o .05 grams
o .08 grams
o .10 grams

164
o .20 grams
o Other __________
o I don’t know
Trajectories_9 Response options for Primary method used:
o Did not use this year
o Joint
o Blunts (cigar sized joints)
o Hand pipe
o Bong (water pipe)
o Hookah
o Vaporizer (e.g. Volcano, vape pen)
o E-cigarette device (sold for nicotine)
o Dab rig (e.g. oil rig, hot knives)
o Edibles
o Topicals (e.g., lotions, creams)
o Other ___________
Trajectories_10 Response options for Additional methods used:
o Did not use this year
o Joint
o Blunts (cigar sized joints)
o Hand pipe
o Bong (water pipe)
o Hookah
o Vaporizer (e.g. Volcano, vape pen)
o E-cigarette device (sold for nicotine)
o Dab rig (e.g. oil rig, hot knives)
o Edibles
o Topicals (e.g., lotions, creams)
o Other ___________
Trajectories_11 Did your primary method of ingestion change from the year before
this?
o Did not use this year
o Yes
o No
Trajectories_12 Response options for Why did method of ingestion change:
o Did not use this year
o Different kind of high
o Stronger intoxication effect
o Effect last longer
o Fewer “hits” are necessary
o Safer to use
o Less side effects
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o
o
o
o
o
o

Friends use/recommended this method
Family members use/recommended this method
Tastes better
Is easily accessible
Is less expensive
Other__________
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Contextual Factors
Contextual_1 What is your current state of residence?
(Select from drop down box of states.)
Contextual_2 How easy is it for you to obtain the following forms of marijuana where
you currently live?
Very easy Moderately
Neither Moderately
Very
easy
easy nor
Difficult
Difficult
difficult
Marijuana (e.g.,
o
o
o
o
o
Flower, Bud, Herb)
Edibles
o
o
o
o
o
Concentrates (e.g.,
o
o
o
o
o
Oil, Wax, Shatter,
Butane Hash Oil)
Contextual_3 How easy is it for you to obtain these materials or devices to use marijuana
where you currently live?
Very
Moderately
Neither Moderately
Very
easy
easy
easy nor
Difficult
Difficult
difficult
Joint
o
o
o
o
o
Blunts (cigar sized
o
o
o
o
o
joints)
Hand pipe
o
o
o
o
o
Bong (water pipe)
o
o
o
o
o
Hookah
o
o
o
o
o
Vaporizer (e.g.,
o
o
o
o
o
Volcano, vape pen)
E-cigarette device (sold
o
o
o
o
o
for nicotine)
Dab rig (e.g. oil rig, hot
o
o
o
o
o
knives)
Edibles
o
o
o
o
o
Topicals (e.g., lotions,
o
o
o
o
o
creams)
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Reasons for Primary Method of Marijuana Ingestion
Reasons_1 Which of the following best captures the top reasons why you use the primary
method (Joints) you mentioned earlier to ingest marijuana?
o Different kind of high
o Stronger intoxication effect
o Effect last longer
o Fewer “hits” are necessary
o Safer to use
o Less side effects
o Friends use/recommended this method
o Family members use/recommended this method
o Tastes better
o Is easily accessible
o Is less expensive
o Other _________
Reasons_2 Which other reasons capture why you use the primary method (Joints) you
mentioned earlier to ingest marijuana? [Check all that apply]
Different kind of high
Stronger intoxication effect
Effect last longer
Fewer “hits” are necessary
Safer to use
Less side effects
Friends use/recommended this method
Family members use/recommended this method
Tastes better
Is easily accessible
Is less expensive
Other _________
Reasons_1b Which of the following best captures the top reasons why you use the
primary method (Blunts) you mentioned earlier to ingest marijuana?
o Different kind of high
o Stronger intoxication effect
o Effect last longer
o Fewer “hits” are necessary
o Safer to use
o Less side effects
o Friends use/recommended this method
o Family members use/recommended this method
o Tastes better
o Is easily accessible
o Is less expensive
o Other _________
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Reasons_2b Which other reasons capture why you use the primary method (Blunts) you
mentioned earlier to ingest marijuana? [Check all that apply]
Different kind of high
Stronger intoxication effect
Effect last longer
Fewer “hits” are necessary
Safer to use
Less side effects
Friends use/recommended this method
Family members use/recommended this method
Tastes better
Is easily accessible
Is less expensive
Other _________
Reasons_1c Which of the following best captures the top reasons why you use the
primary method (Hand pipe) you mentioned earlier to ingest marijuana?
o Different kind of high
o Stronger intoxication effect
o Effect last longer
o Fewer “hits” are necessary
o Safer to use
o Less side effects
o Friends use/recommended this method
o Family members use/recommended this method
o Tastes better
o Is easily accessible
o Is less expensive
o Other _________
Reasons_2c Which other reasons capture why you use the primary method (Hand pipe)
you mentioned earlier to ingest marijuana? [Check all that apply]
Different kind of high
Stronger intoxication effect
Effect last longer
Fewer “hits” are necessary
Safer to use
Less side effects
Friends use/recommended this method
Family members use/recommended this method
Tastes better
Is easily accessible
Is less expensive
Other _________
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Reasons_1d Which of the following best captures the top reasons why you use the
primary method (Bong) you mentioned earlier to ingest marijuana?
o Different kind of high
o Stronger intoxication effect
o Effect last longer
o Fewer “hits” are necessary
o Safer to use
o Less side effects
o Friends use/recommended this method
o Family members use/recommended this method
o Tastes better
o Is easily accessible
o Is less expensive
o Other _________
Reasons_2d Which other reasons capture why you use the primary method (Bong) you
mentioned earlier to ingest marijuana? [Check all that apply]
Different kind of high
Stronger intoxication effect
Effect last longer
Fewer “hits” are necessary
Safer to use
Less side effects
Friends use/recommended this method
Family members use/recommended this method
Tastes better
Is easily accessible
Is less expensive
Other _________
Reasons_1e Which of the following best captures the top reasons why you use the
primary method (Hookah) you mentioned earlier to ingest marijuana?
o Different kind of high
o Stronger intoxication effect
o Effect last longer
o Fewer “hits” are necessary
o Safer to use
o Less side effects
o Friends use/recommended this method
o Family members use/recommended this method
o Tastes better
o Is easily accessible
o Is less expensive
o Other _________
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Reasons_2e Which other reasons capture why you use the primary method (Hookah) you
mentioned earlier to ingest marijuana? [Check all that apply]
Different kind of high
Stronger intoxication effect
Effect last longer
Fewer “hits” are necessary
Safer to use
Less side effects
Friends use/recommended this method
Family members use/recommended this method
Tastes better
Is easily accessible
Is less expensive
Other _________
Reasons_1f Which of the following best captures the top reasons why you use the
primary method (Vaporizer or vape pen) you mentioned earlier to ingest marijuana?
o Different kind of high
o Stronger intoxication effect
o Effect last longer
o Fewer “hits” are necessary
o Safer to use
o Less side effects
o Friends use/recommended this method
o Family members use/recommended this method
o Tastes better
o Is easily accessible
o Is less expensive
o Other _________
Reasons_2f Which other reasons capture why you use the primary method (Vaporizer or
vape pen) you mentioned earlier to ingest marijuana? [Check all that apply]
Different kind of high
Stronger intoxication effect
Effect last longer
Fewer “hits” are necessary
Safer to use
Less side effects
Friends use/recommended this method
Family members use/recommended this method
Tastes better
Is easily accessible
Is less expensive
Other _________
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Reasons_1g Which of the following best captures the top reasons why you use the
primary method (e-cigarette device; sold for nicotine) you mentioned earlier to ingest
marijuana?
o Different kind of high
o Stronger intoxication effect
o Effect last longer
o Fewer “hits” are necessary
o Safer to use
o Less side effects
o Friends use/recommended this method
o Family members use/recommended this method
o Tastes better
o Is easily accessible
o Is less expensive
o Other _________
Reasons_2g Which other reasons capture why you use the primary method (e-cigarette
device; sold for nicotine) you mentioned earlier to ingest marijuana? [Check all that
apply]
Different kind of high
Stronger intoxication effect
Effect last longer
Fewer “hits” are necessary
Safer to use
Less side effects
Friends use/recommended this method
Family members use/recommended this method
Tastes better
Is easily accessible
Is less expensive
Other _________
Reasons_1h Which of the following best captures the top reasons why you use the
primary method (Dab rig; e.g., oil rig, hot knives) you mentioned earlier to ingest
marijuana?
o Different kind of high
o Stronger intoxication effect
o Effect last longer
o Fewer “hits” are necessary
o Safer to use
o Less side effects
o Friends use/recommended this method
o Family members use/recommended this method
o Tastes better
o Is easily accessible
o Is less expensive
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o Other _____
Reasons_2h Which other reasons capture why you use the primary method (Dab rig; e.g.,
oil rig, hot knives) you mentioned earlier to ingest marijuana? [Check all that apply]
Different kind of high
Stronger intoxication effect
Effect last longer
Fewer “hits” are necessary
Safer to use
Less side effects
Friends use/recommended this method
Family members use/recommended this method
Tastes better
Is easily accessible
Is less expensive
Other _________
Reasons_1i Which of the following best captures the top reasons why you use the
primary method (Edibles) you mentioned earlier to ingest marijuana?
o Different kind of high
o Stronger intoxication effect
o Effect last longer
o Fewer “hits” are necessary
o Safer to use
o Less side effects
o Friends use/recommended this method
o Family members use/recommended this method
o Tastes better
o Is easily accessible
o Is less expensive
o Other _________
Reasons_2i Which other reasons capture why you use the primary method (Edibles) you
mentioned earlier to ingest marijuana? [Check all that apply]
Different kind of high
Stronger intoxication effect
Effect last longer
Fewer “hits” are necessary
Safer to use
Less side effects
Friends use/recommended this method
Family members use/recommended this method
Tastes better
Is easily accessible
Is less expensive
Other _________
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Reasons_1j Which of the following best captures the top reasons why you use the
primary method (Topicals; lotions, creams) you mentioned earlier to ingest marijuana?
o Different kind of high
o Stronger intoxication effect
o Effect last longer
o Fewer “hits” are necessary
o Safer to use
o Less side effects
o Friends use/recommended this method
o Family members use/recommended this method
o Tastes better
o Is easily accessible
o Is less expensive
o Other _________
Reasons_2j Which other reasons capture why you use the primary method (Topicals;
lotions, creams) you mentioned earlier to ingest marijuana? [Check all that apply]
Different kind of high
Stronger intoxication effect
Effect last longer
Fewer “hits” are necessary
Safer to use
Less side effects
Friends use/recommended this method
Family members use/recommended this method
Tastes better
Is easily accessible
Is less expensive
Other _________
Reasons_1k Which of the following best captures the top reasons why you use the
primary method (Other) you mentioned earlier to ingest marijuana?
o Different kind of high
o Stronger intoxication effect
o Effect last longer
o Fewer “hits” are necessary
o Safer to use
o Less side effects
o Friends use/recommended this method
o Family members use/recommended this method
o Tastes better
o Is easily accessible
o Is less expensive
o Other _________
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Reasons_2k Which other reasons capture why you use the primary method (Other) you
mentioned earlier to ingest marijuana? [Check all that apply]
Different kind of high
Stronger intoxication effect
Effect last longer
Fewer “hits” are necessary
Safer to use
Less side effects
Friends use/recommended this method
Family members use/recommended this method
Tastes better
Is easily accessible
Is less expensive
Other _________
Reasons_3 Which of the following best captures the top reasons why you use the method
of Joints 25% of the time to ingest marijuana?
o Different kind of high
o Stronger intoxication effect
o Effect last longer
o Fewer “hits” are necessary
o Safer to use
o Less side effects
o Friends use/recommended this method
o Family members use/recommended this method
o Tastes better
o Is easily accessible
o Is less expensive
o Other _________
Reasons_4 Which other reasons capture why you use the method of Joints 25% of the
time to ingest marijuana? [Check all that apply]
Different kind of high
Stronger intoxication effect
Effect last longer
Fewer “hits” are necessary
Safer to use
Less side effects
Friends use/recommended this method
Family members use/recommended this method
Tastes better
Is easily accessible
Is less expensive
Other _________
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Reasons_3b Which of the following best captures the top reasons why you use the
method of Blunts 25% of the time to ingest marijuana
o Different kind of high
o Stronger intoxication effect
o Effect last longer
o Fewer “hits” are necessary
o Safer to use
o Less side effects
o Friends use/recommended this method
o Family members use/recommended this method
o Tastes better
o Is easily accessible
o Is less expensive
o Other _________
Reasons_4b Which other reasons capture why you use the method of Blunts 25% of the
time to ingest marijuana? [Check all that apply]
Different kind of high
Stronger intoxication effect
Effect last longer
Fewer “hits” are necessary
Safer to use
Less side effects
Friends use/recommended this method
Family members use/recommended this method
Tastes better
Is easily accessible
Is less expensive
Other _________
Reasons_3c Which of the following best captures the top reasons why you use the
method of Hand pipe 25% of the time to ingest marijuana
o Different kind of high
o Stronger intoxication effect
o Effect last longer
o Fewer “hits” are necessary
o Safer to use
o Less side effects
o Friends use/recommended this method
o Family members use/recommended this method
o Tastes better
o Is easily accessible
o Is less expensive
o Other _________
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Reasons_4c Which other reasons capture why you use the method of Hand pipe 25% of
the time to ingest marijuana? [Check all that apply]
Different kind of high
Stronger intoxication effect
Effect last longer
Fewer “hits” are necessary
Safer to use
Less side effects
Friends use/recommended this method
Family members use/recommended this method
Tastes better
Is easily accessible
Is less expensive
Other _________
Reasons_3d Which of the following best captures the top reasons why you use the
method of Bong 25% of the time to ingest marijuana
o Different kind of high
o Stronger intoxication effect
o Effect last longer
o Fewer “hits” are necessary
o Safer to use
o Less side effects
o Friends use/recommended this method
o Family members use/recommended this method
o Tastes better
o Is easily accessible
o Is less expensive
o Other _________
Reasons_4d Which other reasons capture why you use the method of Bong 25% of the
time to ingest marijuana? [Check all that apply]
Different kind of high
Stronger intoxication effect
Effect last longer
Fewer “hits” are necessary
Safer to use
Less side effects
Friends use/recommended this method
Family members use/recommended this method
Tastes better
Is easily accessible
Is less expensive
Other _________

177
Reasons_3e Which of the following best captures the top reasons why you use the
method of Hookah 25% of the time to ingest marijuana
o Different kind of high
o Stronger intoxication effect
o Effect last longer
o Fewer “hits” are necessary
o Safer to use
o Less side effects
o Friends use/recommended this method
o Family members use/recommended this method
o Tastes better
o Is easily accessible
o Is less expensive
o Other _________
Reasons_4e Which other reasons capture why you use the method of Hookah 25% of the
time to ingest marijuana? [Check all that apply]
Different kind of high
Stronger intoxication effect
Effect last longer
Fewer “hits” are necessary
Safer to use
Less side effects
Friends use/recommended this method
Family members use/recommended this method
Tastes better
Is easily accessible
Is less expensive
Other _________
Reasons_3f Which of the following best captures the top reasons why you use the method
of Vaporizer 25% of the time to ingest marijuana
o Different kind of high
o Stronger intoxication effect
o Effect last longer
o Fewer “hits” are necessary
o Safer to use
o Less side effects
o Friends use/recommended this method
o Family members use/recommended this method
o Tastes better
o Is easily accessible
o Is less expensive
o Other _________

178
Reasons_4f Which other reasons capture why you use the method of Vaporizer 25% of
the time to ingest marijuana? [Check all that apply]
Different kind of high
Stronger intoxication effect
Effect last longer
Fewer “hits” are necessary
Safer to use
Less side effects
Friends use/recommended this method
Family members use/recommended this method
Tastes better
Is easily accessible
Is less expensive
Other _________
Reasons_3g Which of the following best captures the top reasons why you use the
method of e-cigarette device (sold for nicotine) 25% of the time to ingest marijuana
o Different kind of high
o Stronger intoxication effect
o Effect last longer
o Fewer “hits” are necessary
o Safer to use
o Less side effects
o Friends use/recommended this method
o Family members use/recommended this method
o Tastes better
o Is easily accessible
o Is less expensive
o Other _________
Reasons_4g Which other reasons capture why you use the method of e-cigarette device
(sold for nicotine) 25% of the time to ingest marijuana? [Check all that apply]
Different kind of high
Stronger intoxication effect
Effect last longer
Fewer “hits” are necessary
Safer to use
Less side effects
Friends use/recommended this method
Family members use/recommended this method
Tastes better
Is easily accessible
Is less expensive
Other _________
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Reasons_3h Which of the following best captures the top reasons why you use the
method of Dab rig (e.g., oil rig, hot knives) 25% of the time to ingest marijuana
o Different kind of high
o Stronger intoxication effect
o Effect last longer
o Fewer “hits” are necessary
o Safer to use
o Less side effects
o Friends use/recommended this method
o Family members use/recommended this method
o Tastes better
o Is easily accessible
o Is less expensive
o Other _________
Reasons_4h Which other reasons capture why you use the method of Dab rig (e.g., oil
rig, hot knives) 25% of the time to ingest marijuana? [Check all that apply]
Different kind of high
Stronger intoxication effect
Effect last longer
Fewer “hits” are necessary
Safer to use
Less side effects
Friends use/recommended this method
Family members use/recommended this method
Tastes better
Is easily accessible
Is less expensive
Other _________
Reasons_3i Which of the following best captures the top reasons why you use the method
of Edibles 25% of the time to ingest marijuana
o Different kind of high
o Stronger intoxication effect
o Effect last longer
o Fewer “hits” are necessary
o Safer to use
o Less side effects
o Friends use/recommended this method
o Family members use/recommended this method
o Tastes better
o Is easily accessible
o Is less expensive
o Other _________
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Reasons_4i Which other reasons capture why you use the method of Edibles 25% of the
time to ingest marijuana? [Check all that apply]
Different kind of high
Stronger intoxication effect
Effect last longer
Fewer “hits” are necessary
Safer to use
Less side effects
Friends use/recommended this method
Family members use/recommended this method
Tastes better
Is easily accessible
Is less expensive
Other _________
Reasons_3j Which of the following best captures the top reasons why you use the method
of Topicals (e,g., lotions, creams) 25% of the time to ingest marijuana
o Different kind of high
o Stronger intoxication effect
o Effect last longer
o Fewer “hits” are necessary
o Safer to use
o Less side effects
o Friends use/recommended this method
o Family members use/recommended this method
o Tastes better
o Is easily accessible
o Is less expensive
o Other _________
Reasons_4j Which other reasons capture why you use the method of Topicals (e.g.,
lotions, creams) 25% of the time to ingest marijuana? [Check all that apply]
Different kind of high
Stronger intoxication effect
Effect last longer
Fewer “hits” are necessary
Safer to use
Less side effects
Friends use/recommended this method
Family members use/recommended this method
Tastes better
Is easily accessible
Is less expensive
Other _________
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Reasons_3k Which of the following best captures the top reasons why you use the
method of Other 25% of the time to ingest marijuana
o Different kind of high
o Stronger intoxication effect
o Effect last longer
o Fewer “hits” are necessary
o Safer to use
o Less side effects
o Friends use/recommended this method
o Family members use/recommended this method
o Tastes better
o Is easily accessible
o Is less expensive
o Other _________
Reasons_4k Which other reasons capture why you use the method of Other 25% of the
time to ingest marijuana? [Check all that apply]
Different kind of high
Stronger intoxication effect
Effect last longer
Fewer “hits” are necessary
Safer to use
Less side effects
Friends use/recommended this method
Family members use/recommended this method
Tastes better
Is easily accessible
Is less expensive
Other _________
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CONSENT FOR HUMAN PARTICIPANTS IN RESEARCH
UNIVERSITY OF NORTHERN COLORADO

Project Title: Current Trends in Marijuana Methods of Ingestion Among Young Adult
Marijuana Users
Researcher: Maryia Schneider, M.A.
Email: schn8458@bears.unco.edu
Faculty Researchers: David Hulac, Ph.D. & Kristina Phillips, Ph.D.
Faculty contact: David.Hulac@unco.edu
Purpose and Description
We are currently recruiting community members over the age of 18 to participate in a
research study on marijuana use and methods of ingestion. The goal of this study is to
learn more about how you are using marijuana, both currently and since you first began
using.
As part of this study, you will be asked to fill out a survey that takes approximately 20-30
minutes to complete.
Your participation in this survey is voluntary. You may refuse to take part in the research
or exit the survey at any time without penalty. You will be asked to answer questions
regarding yourself, your marijuana use over time, and any emotional concerns. Your
responses will help us learn more about methods of marijuana ingestion.
Some of the questions concern sensitive information about you. Most people do not
experience any discomfort when answering such questions, but others may find
answering these questions uncomfortable. There are no foreseeable risks involved in
participating in this study.
Your responses to the questions will be anonymous. No identifying information about
your responses will be provided to anyone outside of this study. Information that is
collected via the survey software program are stored in a single secure data center (not in
the cloud). We will not ask any information that identifies you (e.g., your name of social
security number) on the survey link. All paper research records will be kept in a locked
file; only the researchers will have access to the records. All date will be destroyed three
years after study completion.
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While there are no direct benefits from participating in this study, there is an indirect
benefit of knowing you participated in a study that will support research focused on
marijuana use. Participants are financially reimbursed for their participation. The
reimbursement for completing the study will be $2.50 paid through Amazon.
If you have questions at any time about the study or the procedures, you may contact
Maryia Schneider at schn8458@bears.unco.edu.
Participation is voluntary. You may decide not to participate in this study and if you
begin participation you may still decide to stop and withdraw at any time. Your decision
will be respected and will not result in loss of benefits to which you are otherwise
entitled. Having read the above and having had an opportunity to ask any questions,
please sign below if you would like to participate in this research. You may print a copy
of this form to retain for future reference. If you have any concerns about your selection
or treatment as a research participant, please contact the Office of Research, Kepner Hall,
University of Northern Colorado Greeley, CO 80639; 970-351-1910.
ELECTRONIC CONSENT: Please select your choice below. You may print a copy of
this consent form for your records. Clicking on the “Agree” button indicates that
•
•
•
•

You have read the above information
You voluntarily agree to participate
You are 18 years of age or older
You currently use marijuana at least monthly
Agree
Disagree
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CONSENT FOR HUMAN PARTICIPANTS IN RESEARCH
UNIVERSITY OF NORTHERN COLORADO

Project Title: Current Trends in Marijuana Methods of Ingestion Among Young Adult
Marijuana Users
Researcher: Maryia Schneider, M.A.
Email: schn8458@bears.unco.edu
Faculty Researchers: David Hulac, Ph.D. & Kristina Phillips, Ph.D.
Faculty contact: David.Hulac@unco.edu
Purpose and Description
We are currently recruiting community members over the age of 18 to participate in a
research study on marijuana use and methods of ingestion. The goal of this study is to
learn more about how you are using marijuana, both currently and since you first began
using.
As part of this study, you will be asked to fill out a survey that takes approximately 20-30
minutes to complete.
Your participation in this survey is voluntary. You may refuse to take part in the research
or exit the survey at any time without penalty. You will be asked to answer questions
regarding yourself, your marijuana use over time, and any emotional concerns. Your
responses will help us learn more about methods of marijuana ingestion.
Some of the questions concern sensitive information about you. Most people do not
experience any discomfort when answering such questions, but others may find
answering these questions uncomfortable. There are no foreseeable risks involved in
participating in this study.
Your responses to the questions will be anonymous. No identifying information about
your responses will be provided to anyone outside of this study. Information that is
collected via the survey software program are stored in a single secure data center (not in
the cloud). We will not ask any information that identifies you (e.g., your name of social
security number) on the survey link. All paper research records will be kept in a locked
file; only the researchers will have access to the records. All date will be destroyed three
years after study completion.
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While there are no direct benefits from participating in this study, there is an indirect
benefit of knowing you participated in a study that will support research focused on
marijuana use. Participants are not financially reimbursed for their participation.
If you have questions at any time about the study or the procedures, you may contact
Maryia Schneider at schn8458@bears.unco.edu.
Participation is voluntary. You may decide not to participate in this study and if you
begin participation you may still decide to stop and withdraw at any time. Your decision
will be respected and will not result in loss of benefits to which you are otherwise
entitled. Having read the above and having had an opportunity to ask any questions,
please sign below if you would like to participate in this research. You may print a copy
of this form to retain for future reference. If you have any concerns about your selection
or treatment as a research participant, please contact the Office of Research, Kepner Hall,
University of Northern Colorado Greeley, CO 80639; 970-351-1910.
ELECTRONIC CONSENT: Please select your choice below. You may print a copy of
this consent form for your records. Clicking on the “Agree” button indicates that
•
•
•
•

You have read the above information
You voluntarily agree to participate
You are 18 years of age or older
You currently use marijuana at least monthly
Agree
Disagree

